UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2021~~2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

OF 1934

For the transition period from _________ to __________

COMMISSION FILE NUMBER 1-33926

TRECORA RESOURCES

(Exact name of registrant as specified in its charter)


Delaware			75-1256622
(State or other jurisdiction of			(I.R.S. Employer Identification No.)
incorporation or organization)


1650 Hwy 6 South,	Suite 190	77478
Sugar Land,	Texas
(Address of principal executive offices)		(Zip code)

Registrant's telephone number, including area code: (281) 980-5522

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.10 per share	TREC	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S–T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes X No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☒

Non-accelerated filer ☐ Smaller reporting company ☒

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.~~____~~ ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Number of shares of the Registrant's Common Stock (par value $0.10 per share) outstanding at ~~October~~May 224, ~~2021~~2022: 2423,~~402~~651,~~392~~141.

TABLE OF CONTENTS

Item Number and Description

PART I – FINANCIAL INFORMATION
ITEM 1. Financial Statements
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Statement of Stockholders' Equity	3
	Condensed Consolidated Statements of Cash Flows	54
	Notes to Condensed Consolidated Financial Statements	65
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations		2014
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk		3321
ITEM 4. Controls and Procedures		3321
	PART II – OTHER INFORMATION
ITEM 1. Legal Proceedings		3422
ITEM 1A. Risk Factors		3422
ITEM 6. Exhibits		3422

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2021 (Unaudited)		December 31, 2020
	March 31, 2022 (Unaudited)		December 31, 2021
ASSETS	(thousands of dollars, except par value)
Current Assets
Cash	$	4431,~~403~~937	$	5530,~~664~~535
Trade receivables, net	3133,~~958~~572		2532,~~301~~811
Inventories	1520,~~619~~355		1221,~~945~~134
Prepaid expenses and other assets	63,~~643~~396		94,~~198~~313
Taxes receivable	945		2,788
Total current assets	89,260		88,793
Total current assets	99,568		105,896
Property, plant and equipment, net	186,029		185,521
Property, plant and equipment, net	187,567		187,104
Intangible assets, net	10,601		11,056
Intangible assets, net	11,512		12,893
Lease right-of-use assets, net	7,305		8,170
Lease right-of-use assets, net	8,746		10,528
TOTAL ASSETS	$	293,195	$	293,540
Mineral properties in the United States	412		412
TOTAL ASSETS	$	307,805	$	316,833
LIABILITIES
Current Liabilities
Accounts payable	$	12,~~686~~387	$	1412,~~447~~075
Accrued liabilities	117,~~044~~123		65,~~857~~873
Current portion of long-term debt	4,194		4,194
Current portion of lease liabilities	3,~~302~~085		3,~~195~~227
Current portion of CARES Act, PPP Loans	3,935		—
Current portion of other liabilities	620		626
Current portion of other liabilities	542		891
Total current liabilities	27,409		25,995
Total current liabilities	35,703		29,584
Long-term debt, net of current portion	36,658		37,707
CARES Act, PPP Loans, net of current portion	—		6,123
Lease liabilities, net of current portion	4,202		4,923
Long-term debt, net of current portion	38,755		41,901
Other liabilities, net of current portion	403		417
Post-retirement benefit, net of current portion	312		320
Deferred income taxes	24,771		24,525
Lease liabilities, net of current portion	5,444		7,333
Total liabilities	93,443		93,567
Other liabilities, net of current portion	617		648
COMMITMENTS AND CONTINGENCIES (Note 11)
Deferred income taxes	26,420		26,517
Total liabilities	107,251		112,426
COMMITMENTS AND CONTINGENCIES (Note 12)
EQUITY
Common stock - authorized 40 million shares of $0.10 par value; issued 25.0 million and 24.8 million and outstanding 24.4 million and 24.8 million in 2021 and 2020, respectively	2,497		2,483
Common stock - authorized 40 million shares of $0.10 par value; issued 25.1 million and 25.0 million and outstanding 23.7 million and 23.6 million in 2022 and 2021, respectively	2,508		2,499
Additional paid-in capital	6263,~~710~~406		6163,~~311~~260
Treasury stock, at cost (0.6 million shares)	(5,000)		—
Treasury stock, at cost (1.4 million shares)	(11,486)		(11,486)
Retained earnings	~~140~~145,~~058~~324		~~140~~145,~~324~~700
Total Trecora Resources Stockholders' Equity	200,265		204,118
Total equity	199,752		199,973
Non-controlling Interest	289		289
TOTAL LIABILITIES AND EQUITY	$	293,195	$	293,540
Total equity	200,554		204,407
TOTAL LIABILITIES AND EQUITY	$	307,805	$	316,833

See notes to condensed consolidated financial statements.


Table of Contents
			1

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

	THREE MONTHSENDEDSEPTEMBER 30,				NINE MONTHSENDEDSEPTEMBER 30,
	THREE MONTHSENDEDMARCH 31,
	2021		2020		2021		2020
	2022		2021
	(thousands of dollars, except per share amounts)
REVENUES
Product sales	$	7079,~~422~~061	$	4351,~~570~~565	$	~~186,647~~	$	~~137,460~~
Processing fees	4,~~215~~153		43,~~177~~020		~~11,424~~		~~13,028~~
	74,637		47,747		198,071		150,488
	83,214		54,585
OPERATING COSTS AND EXPENSES
Cost of sales and processing (including depreciation and amortization of $4,180, $3,887, $12,317 and $11,373, respectively)	65,663		39,290		175,731		127,786
Cost of sales and processing (including depreciation and amortization of $4,079 and $4,055, respectively)	75,321		52,240
GROSS PROFIT	87,~~974~~893		82,~~457~~345		~~22,340~~		~~22,702~~
GENERAL AND ADMINISTRATIVE EXPENSES
General and administrative	87,~~923~~533		57,~~766~~332		~~23,928~~		~~18,729~~
Depreciation	~~218~~228		~~209~~226		~~670~~		~~637~~
	9,141		5,975		24,598		19,366
	7,761		7,558
OPERATING INCOME (LOSS)	~~(167)~~132		2(5,~~482~~213)		~~(2,258)~~		~~3,336~~
OTHER INCOME (EXPENSE)
Interest expense	(~~319~~283)		(~~508~~302)		~~(918)~~		~~(2,159)~~
Gain on extinguishment of debt	2,188		—		2,188		—
Miscellaneous income, net	69		110
Miscellaneous income, net	(30)		(13)		213		(7)
	(214)		(192)
	1,839		(521)		1,483		(2,166)
INCOME (LOSS) BEFORE INCOME TAXES	(82)		(5,405)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	1,672		1,961		(775)		1,170
INCOME TAX (EXPENSE) BENEFIT	(294)		1,001
INCOME TAX (EXPENSE) BENEFIT	211		(853)		509		3,942
NET INCOME (LOSS)	$	(376)	$	(4,404)
INCOME (LOSS) FROM CONTINUING OPERATIONS	1,883		1,108		(266)		5,112
INCOME FROM DISCONTINUED OPERATIONS, NET OF TAX	—		21,324		—		26,179
NET INCOME (LOSS)	$	1,883	$	22,432	$	(266)	$	31,291
Basic Earnings (Loss) per Common Share
Net income (loss) from continuing operations (dollars)	$	0.08	$	0.04	$	(0.01)	$	0.21
Net loss (dollars)	$	(0.02)	$	(0.18)
Net income from discontinued operations, net of tax (dollars)	—		0.86		—		1.06
Basic weighted average number of common shares outstanding	23,600		24,861
Net income (loss) (dollars)	$	0.08	$	0.90	$	(0.01)	$	1.27
Basic weighted average number of common shares outstanding	24,341		24,817		24,562		24,795
Diluted Earnings (Loss) per Common Share
Net income (loss) from continuing operations (dollars)	$	0.08	$	0.04	$	(0.01)	$	0.20
Net loss (dollars)	$	(0.02)	$	(0.18)
Net income from discontinued operations, net of tax (dollars)	—		0.84		—		1.04
Diluted weighted average number of common shares outstanding	23,600		24,861
Net income (loss) (dollars)	$	0.08	$	0.88	$	(0.01)	$	1.24
Diluted weighted average number of common shares outstanding	24,952		25,394		24,562		25,179

See notes to condensed consolidated financial statements.


Table of Contents
			2

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED ~~STATEMENT~~STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

THREE MONTHS ENDED ~~SEPTEMBER~~MARCH 3031

	TRECORA RESOURCES STOCKHOLDERS
	COMMON STOCK			ADDITIONALPAID-IN		TREASURY		RETAINED				NON-CONTROLLING		TOTAL
	SHARES	AMOUNT		CAPITAL		STOCK		EARNINGS		TOTAL		INTEREST		EQUITY
	(thousands)	(thousands of dollars)
June 30, 2021	24,973	$	2,497	$	62,138	$	(5,000)	$	138,175	$	197,810	$	289	$	198,099
December 31, 2021	24,990	$	2,499	$	63,260	$	(11,486)	$	145,700	$	199,973	$	—	$	199,973
Restricted Stock Units
Issued to Directors	—	—		~~439~~133		—		—		~~439~~133		—		~~439~~133
Issued to Employees	—	—		~~133~~22		—		—		~~133~~22		—		~~133~~22
Common Stock
Issued to Directors	—	—		—		—		—		—		—		—
Issued to Employees	85	9		(9)		—		—		—		—		—
Issued to Employees	—	—		—		—		—		—		—		—
Net Loss	—	—		—		—		(376)		(376)		—		(376)
Stock Repurchases	—	—		—		—		—		—		—		—
March 31, 2022	25,075	$	2,508	$	63,406	$	(11,486)	$	145,324	$	199,752	$	—	$	199,752
Net Income	—	—		—		—		1,883		1,883		—		1,883
December 31, 2020	24,833	$	2,483	$	61,311	$	—	$	140,324	$	204,118	$	289	$	204,407
September 30, 2021	24,973	$	2,497	$	62,710	$	(5,000)	$	140,058	$	200,265	$	289	$	200,554
June 30, 2020	24,817	$	2,482	$	60,386	$	—	$	118,008	$	180,876	$	289	$	181,165
Restricted Stock Units
Issued to Directors	—	—		113		—		—		113		—		113
Issued to Employees	—	—		~~376~~275		—		—		~~376~~275		—		~~376~~275
Common Stock
Issued to Directors	—	—		—		—		—		—		—		—
Issued to Employees	61	7		(7)		—		—		—		—		—
Issued to Employees	—	—		—		—		—		—		—		—
Net Loss	—	—		—		—		(4,404)		(4,404)		—		(4,404)
Net Income	—	—		—		—		22,432		22,432		—		22,432
March 31, 2021	24,894	$	2,490	$	61,692	$	—	$	135,920	$	200,102	$	289	$	200,391
September 30, 2020	24,817	$	2,482	$	60,875	$	—	$	140,440	$	203,797	$	289	$	204,086

See notes to condensed consolidated financial statements.


Table of Contents
			3

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED ~~STATEMENT~~STATEMENTS OF ~~STOCKHOLDERS'~~CASH ~~EQUITY~~FLOWS (UNAUDITED)

NINE MONTHS ENDED SEPTEMBER 30


	THREE MONTHS ENDED MARCH 31,
	2022		2021
	(thousands of dollars)
OPERATING ACTIVITIES
Net Income (Loss)	$	(376)	$	(4,404)


Adjustments to Reconcile Net Income (Loss) To Net Cash Provided by Operating Activities:
Depreciation and Amortization	3,851		3,820
Amortization of Intangible Assets	456		461

Stock-based Compensation	524		571
Deferred Income Taxes	246		(924)


Amortization of Loan Fees	45		45
Gain on Disposal of Assets	—		(254)

Other Non-cash Items (Note 6)	515		—
Changes in Operating Assets and Liabilities:
(Increase) Decrease in Trade Receivables	(762)		(628)


(Increase) Decrease in Inventories	779		1,206
(Increase) Decrease in Prepaid Expenses and Other Assets	916		2,803
Increase (Decrease) in Accounts Payable and Accrued Liabilities	1,527		1,282
Increase (Decrease) in Other Liabilities	(4)		(147)


Net Cash Provided by Operating Activities	7,717		3,831
INVESTING ACTIVITIES
Additions to Property, Plant and Equipment	(4,851)		(4,781)
Proceeds from Sale of Property, Plant and Equipment	—		281


Net Cash Used in Investing Activities	(4,851)		(4,500)
FINANCING ACTIVITIES
Repurchase of Common Stock	—		(692)
Net Cash Paid Related to Stock-Based Compensation	(370)		(183)


Repayments of Long-Term Debt	(1,094)		(1,094)
Net Cash Used in Financing Activities	(1,464)		(1,969)
NET INCREASE (DECREASE) INCREASE IN CASH	1,402		(2,638)
CASH AT BEGINNING OF PERIOD	30,535		55,664
CASH AT END OF PERIOD	$	31,937	$	53,026
Supplemental disclosure of cash flow information:
Cash payments for interest	$	237	$	257

Supplemental disclosure of non-cash items:
Capital expansion amortized to depreciation expense	$	11	$	116

Foreign taxes paid	$	—	$	1,054

	TRECORA RESOURCES STOCKHOLDERS
	COMMON STOCK			ADDITIONALPAID-IN		TREASURY		RETAINED				NON-CONTROLLING		TOTAL
	SHARES	AMOUNT		CAPITAL		STOCK		EARNINGS		TOTAL		INTEREST		EQUITY
	(thousands)	(thousands of dollars)
January 1, 2021	24,833	$	2,483	$	61,311	$	—	$	140,324	$	204,118	$	289	$	204,407
Restricted Stock Units
Issued to Directors	—	—		304		—		—		304		—		304
Issued to Employees	—	—		1,109		—		—		1,109		—		1,109
Common Stock
Issued to Directors	68	7		(7)		—		—		—		—		—
Issued to Employees	72	7		(7)		—		—		—		—		—
Stock Repurchases	—	—		—		(5,000)		—		(5,000)		—		(5,000)
Net Loss	—	—		—		—		(266)		(266)		—		(266)
September 30, 2021	24,973	$	2,497	$	62,710	$	(5,000)	$	140,058	$	200,265	$	289	$	200,554
January 1, 2020	24,750	$	2,475	$	59,530	$	—	$	109,149	$	171,154	$	289	$	171,443
Restricted Stock Units
Issued to Directors	—	—		308		—		—		308		—		308
Issued to Employees	—	—		1,044		—		—		1,044		—		1,044
Common Stock
Issued to Directors	28	3		(3)		—		—		—		—		—
Issued to Employees	39	4		(4)		—		—		—		—		—
Net Income	—	—		—		—		31,291		31,291		—		31,291
September 30, 2020	24,817	$	2,482	$	60,875	$	—	$	140,440	$	203,797	$	289	$	204,086

See notes to condensed consolidated financial statements.


Table of Contents
			4

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

	NINE MONTHS ENDEDSEPTEMBER 30,
	2021		2020
	(thousands of dollars)
OPERATING ACTIVITIES
Net Income (Loss)	$	(266)	$	31,291
Income from Discontinued Operations	—		26,179
Income (Loss) from Continuing Operations	$	(266)	$	5,112
Adjustments to Reconcile Income (Loss) from Continuing Operations To Net Cash Provided by Operating Activities:
Depreciation and Amortization	11,604		10,629
Amortization of Intangible Assets	1,382		1,382
Stock-based Compensation	1,695		1,423
Deferred Income Taxes	(96)		14,168
Postretirement Obligation	(22)		(1)
Bad Debt Expense	—		(1)
Amortization of Loan Fees	136		136
(Gain) Loss on Disposal of Assets	(280)		9
Gain on Extinguishment of Debt	(2,188)		—
Changes in Operating Assets and Liabilities:
(Increase) Decrease in Trade Receivables	(6,657)		3,665
Decrease in Insurance Receivables	—		1,148
(Increase) Decrease in Taxes Receivable	1,843		(16,675)
(Increase) Decrease in Inventories	(2,674)		2,514
(Increase) Decrease in Prepaid Expenses and Other Assets	2,554		(1,370)
Increase (Decrease) in Accounts Payable and Accrued Liabilities	2,426		(950)
Increase (Decrease) in Other Liabilities	(141)		510
Net Cash Provided by Operating Activities - Continuing Operations	9,316		21,699
Net Cash Used in Operating Activities - Discontinued Operations	—		(4,124)
Net Cash Provided by Operating Activities	9,316		17,575
INVESTING ACTIVITIES
Additions to Property, Plant and Equipment	(12,295)		(10,309)
Proceeds from Sale of Property, Plant and Equipment	281		150
Net Cash Used in Investing Activities - Continuing Operations	(12,014)		(10,159)
Net Cash Provided by Investing Activities - Discontinued Operations	—		68,530
Net Cash Provided by (Used in) Investing Activities	(12,014)		58,371
FINANCING ACTIVITIES
Repurchase of Common Stock	(5,000)		—
Net Cash Paid Related to Stock-Based Compensation	(282)		(71)
Additions to CARES Act, PPP Loans	—		6,123
Additions to Long-Term Debt	—		20,000
Repayments of Long-Term Debt	(3,281)		(56,281)
Net Cash Used in Financing Activities - Continuing Operations	(8,563)		(30,229)
NET (DECREASE) INCREASE IN CASH	(11,261)		45,717
CASH AT BEGINNING OF PERIOD	55,664		6,145
CASH AT END OF PERIOD	$	44,403	$	51,862
Supplemental disclosure of cash flow information:
Cash payments for interest	$	744	$	2,023
Cash payments for taxes, net of refunds	$	(2,140)	$	3,000
Supplemental disclosure of non-cash items:
Capital expansion amortized to depreciation expense	$	225	$	690
Foreign taxes paid by AMAK	$	1,054	$	240

See notes to consolidated financial statements.

Table of Contents 5

TRECORA RESOURCES AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. GENERAL

Organization

Trecora Resources (the “Company”) was incorporated in the State of Delaware in 1967. The Company's principal business activities are the manufacturing of various specialty petrochemical products, specialty waxes and providing custom processing services.

The Company’s specialty petrochemicals operations are primarily conducted through its wholly-owned subsidiary, Texas Oil and Chemical Co. II, Inc. (“TOCCO”). TOCCO owns all of the capital stock of South Hampton Resources, Inc. (“SHR”) and Trecora Chemical, Inc. (“TC”). SHR owns all of the capital stock of Gulf State Pipe Line Company, Inc. (“GSPL”). SHR owns and operates a specialty petrochemicals product facility in Silsbee, Texas which manufactures high purity hydrocarbons used primarily in polyethylene, packaging, polypropylene, expandable polystyrene, poly-iso/urethane foams, Canadian tar sands, and in the catalyst support industry. TC owns and operates a facility located in Pasadena, Texas which manufactures specialty waxes and provides custom processing services. These specialty waxes are used in the production of coatings, hot melt adhesives and lubricants. GSPL owns and operates pipelines that connect the SHR facility to a natural gas line, to SHR’s truck and rail loading terminal and to a major petroleum pipeline owned by an unaffiliated third party.

The Company ~~owns~~previously ~~approximately~~owned a 55% ofownership ~~the~~interest ~~capital~~in ~~stock~~an ofinactive ~~a Nevada~~ mining ~~company~~corporation, Pioche Ely Valley Mines, Inc. (“PEVM”), which ~~does~~was ~~not~~previously ~~conduct~~presented ~~any~~as ~~substantial~~a ~~business~~non-controlling ~~activity~~interest ~~but~~on ~~owns~~the ~~undeveloped~~Company's ~~properties~~financial statements. In November 2019, PEVM entered into a sales contract to sell all of its assets, which include 48 patented and 5 unpatented claims totaling approximately 1,500 acres. The sale was completed on November 1, 2021 and resulted in liquidation of substantially all of PEVM's remaining assets. Proceeds from the ~~United~~sale ~~States~~were used to repay outstanding indebtedness of PEVM owed to the Company. PEVM was legally dissolved on February 16, 2022.

The Company also previously owned 33% of a Saudi Arabian joint stock company, Al Masane Al Kobra Mining Company (“AMAK”). The final closing of the sale of our ownership interest in AMAK was completed on September 28, 2020. For more information, see Note 5.

For convenience in this report, the terms “Company”, “our”, “us”, “we” or “TREC” may be used to refer to Trecora Resources and its subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and, therefore, should be read in conjunction with the financial statements and related notes contained in the Company's Annual Report on Form 10-K for the year ended December 31, ~~2020~~2021, filed on March 10, 2022, as amended by Amendment No. 1 to such Annual Report on Form 10-K, filed on April 29, 2022 (collectively, the “Annual Report on Form 10-K, as amended”).

The unaudited condensed consolidated financial statements included in this document have been prepared on the same basis as the annual financial statements and in management's opinion reflect all adjustments, including normal recurring adjustments, necessary to present fairly the Company's financial position, results of operations and cash flows for the interim periods presented. We have made estimates and judgments affecting the amounts reported in this document. The actual results that we experience may differ materially from our estimates. In the opinion of management, the disclosures included in these financial statements are adequate to make the information presented not misleading.

Operating results for the ~~nine~~three months ended ~~September~~March 3031, ~~2021~~2022 are not necessarily indicative of results for the year ending December 31, ~~2021~~2022.

We currently operate in two segments, Specialty Petrochemicals and Specialty Waxes. All revenue originates from sources in the United States and all long-lived assets owned are located in the United States.

Reclassifications

Certain prior period balances have been reclassified to conform to the current period presentation in the condensed consolidated financial statements and the accompanying notes.


Table of Contents
			5

2. RECENT ACCOUNTING PRONOUNCEMENTS

Recently Adopted Accounting Pronouncements

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which simplifies the accounting for income taxes. This guidance was effective for us in the first quarter of 2021. The adoption of this guidance did not have a material impact on our consolidated financial statements.

Recent Accounting Pronouncements Not Yet Adopted

~~Table~~In March 2020, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2020–04, Reference Rate Reform (Topic 848): Facilitation of ~~Contents~~the 6Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which provides guidance to alleviate the burden in accounting for reference rate reform by allowing certain expedients and exceptions in applying generally accepted accounting principles to contracts, hedging relationships, and other transactions impacted by reference rate reform. The provisions of ASU 2020-04 apply only to those transactions that reference the London Interbank Offer Rate or another reference rate expected to be discontinued due to reference rate reform. This guidance is effective from March 12, 2020 through December 31, 2022 and adoption is optional. We are currently evaluating the impact of ASU 2020-04 on our consolidated financial statements.

In March 2020, the FASB issued ASU No. 2020–04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04), which provides guidance to alleviate the burden in accounting for reference rate reform by allowing certain expedients and exceptions in applying generally accepted accounting principles to contracts, hedging relationships, and other transactions impacted by reference rate reform. The provisions of ASU 2020-04 apply only to those transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. This guidance is effective from March 12, 2020 through December 31, 2022 and adoption is optional. We are currently evaluating the impact of ASU 2020-04 on our consolidated financial statements.

3. TRADE RECEIVABLES

Trade receivables, net consisted of the following:

September 30, 2021

December 31, 2020

March 31, 2022

December 31, 2021

(thousands of dollars)

Trade receivables

3233,~~258~~872

2533,~~601~~111

Less allowance for doubtful accounts

(300)

Total trade receivables, net

3133,~~958~~572

2532,~~301~~811

Trade receivables serve as collateral for our amended and restated credit agreement. See Note 1110.

4. INVENTORIES

Inventories consisted of the following:

September 30, 2021

December 31, 2020

March 31, 2022

December 31, 2021

(thousands of dollars)

Raw material

15,~~928~~432

2,~~580~~348

Work in process

~~187~~171

~~138~~212

Finished products

1314,~~504~~752

1018,~~227~~574

Total inventories

1520,~~619~~355

1221,~~945~~134

Inventory serves as collateral for our amended and restated credit agreement. See Note 1110.

Inventory included Specialty Petrochemicals products in transit valued at approximately $46.04 million and $34.69 million at ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021, respectively.

5. ~~INVESTMENT~~PREPAID INEXPENSES ~~AMAK~~ AND ~~DISCONTINUED~~OTHER ~~OPERATIONS~~ASSETS

On September 28, 2020, the Company completed the final closing of the sale of its ownership interest in AMAK (the “Share Sale”) to AMAK and certain existing shareholders of AMAK and their assignees (collectively, the “Purchasers”). The Share Sale was completed in multiple closings pursuant to a Share Sale and Purchase Agreement, dated September 22, 2019 (which we refer to herein as the “Purchase Agreement”), among the Company, AMAK, and other Purchasers and resulted in aggregate gross proceeds to the Company of Saudi Riyals (“SAR”) 265 million (approximately $70 million) (before taxes and expenses).


Prepaid expenses and other assets consisted of the following:
	March 31, 2022		December 31, 2021
	(thousands of dollars)
Prepaid license	$	250	$	500
Prepaid insurance premiums	—		1,145
Spare parts	2,561		2,114


Other prepaid expenses and assets	585		554
Total prepaid expenses and other assets	$	3,396	$	4,313

AsTable ~~a condition to the effectiveness~~ of ~~the~~Contents Purchase Agreement, the Purchasers advanced 5% of the purchase price (or approximately $3.5 million) in the form of a non-refundable deposit. Pursuant to the Purchase Agreement, (i) with respect to any Purchaser that completed the purchase of all or a portion of the ordinary shares allotted to it under the Purchase Agreement on or before March 31, 2020, the non-refundable deposit paid by such Purchaser (or a portion of such deposit for a partial closing) was credited toward the purchase price of the ordinary shares being purchased and (ii) with respect to any Purchasers that completed the purchase of all or a portion of their allotted ordinary shares after March 31, 2020 but on or before September 28, 2020, an amount equal to 50% of the non-refundable deposit paid by such Purchasers was forfeited to the Company as liquidated damages and such amount was not applied to the purchase price paid by the applicable Purchaser.6

~~On March 26, 2020, the Company and one Purchaser completed the first closing of the Share Sale (the “First Closing”)~~6. ~~In connection with the First Closing~~PROPERTY, ~~the~~PLANT ~~Company~~AND sold 4,000,000 ordinary shares for aggregate gross proceeds (before taxes and transaction expenses) of SAR 40 million (or approximately $10.7 million) (inclusive of the full amount of the Purchaser’s non-refundable deposit previously paid of $0.5 million). The Company recorded a foreign tax payable of approximately $0.3 million related to the First Closing.EQUIPMENT

During the third quarter of 2020, the Company completed additional closings of the Share Sale with respect to its remaining ownership interest in AMAK. In connection with these closings, the Company sold a total of 22,467,422 ordinary shares for


Property, plant and equipment consisted of the following:
	March 31, 2022		December 31, 2021
	(thousands of dollars)
Platinum catalyst metal	$	1,478	$	1,478
Catalyst	4,325		4,325
Land	5,400		5,428
Plant, pipeline and equipment	286,491		282,780
Construction in progress	7,901		7,213
Total property, plant and equipment	$	305,595	$	301,224
Less accumulated depreciation	(119,566)		(115,703)
Total property, plant and equipment, net	$	186,029	$	185,521

~~Table~~Property, ofplant ~~Contents~~and 7equipment serve as collateral for our amended and restated credit agreement. See Note 10.

~~aggregate~~In ~~gross proceeds (before taxes and transaction expenses) of SAR 224 million (or approximately $59.9 million) (inclusive of $1.5 million which constituted 50% of~~ the ~~non-refundable~~first ~~deposits~~quarter ~~previously paid by certain Purchasers). As none~~ of ~~the third quarter 2020 closings were completed prior to March 31~~2022, ~~2020,~~ the ~~remaining~~Company ~~portion~~donated ~~of the initial deposits (~~approximately $10.5 million) ~~were~~of ~~forfeited~~land toand ~~the~~other ~~Company~~property, asplant ~~liquidated damages~~ and ~~were~~equipment ~~not applied~~ to ~~the~~a ~~purchase~~local ~~price.~~municipal ~~These~~organization, ~~amounts~~which ~~were~~is included in ~~income~~other ~~from~~non-cash ~~discontinued~~items ~~operations,~~on ~~net of tax. The Company recorded a foreign tax payable of approximately $1.1 million related to~~ the ~~third~~condensed ~~quarter~~consolidated ~~2020~~statement ~~closings which were subsequently paid in the first quarter~~ of ~~2021.~~cash flows.

InLabor ~~connection~~capitalized ~~with~~for ~~the~~construction ~~completion~~was ~~of the Share Sale, the Company and AMAK entered into an agreement whereby AMAK agreed to withhold~~ approximately $20.1 million ~~of the purchase price to pay the Company’s estimated tax obligations in Saudi Arabia. The Company finalized the necessary tax returns in the Kingdom of Saudi Arabia~~ and ~~paid approximately~~ $10.36 million infor ~~foreign taxes. All foreign taxes paid created a foreign tax credit to offset U.S. taxes. The Company collected~~ the ~~remaining~~three ~~excess~~months ~~funds~~ended ofMarch ~~approximately~~31, ~~$0.8 million~~2022 inand ~~August~~ 2021, respectively.

AsConstruction ~~previously disclosed, and as a result of the Company’s investment~~ in ~~AMAK,~~progress ~~the~~during ~~Company was required to execute a limited guarantee on October 24, 2010 (~~the ~~“Guarantee”)~~first ofthree upmonths ~~to 41%~~ of a2022 ~~loan~~included ~~(the~~pipeline ~~“Loan”)~~upgrades byand ~~the~~costs ~~Saudi~~related ~~Industrial Development Fund (“SIDF”)~~ to ~~AMAK~~a toscheduled ~~fund~~plant ~~the~~turnaround ~~construction~~late ofin the ~~AMAK~~first ~~facilities~~quarter ~~and~~at toour ~~provide~~Specialty ~~working~~Petrochemicals ~~capital needs~~facility. ~~The~~Construction ~~provision~~in ofprogress ~~personal~~during ~~or corporate guarantees, as applicable, by each shareholder of AMAK was a condition to SIDF providing~~ the ~~Loan.~~first ~~Pursuant~~three tomonths ~~the Purchase Agreement, the Purchasers (other than AMAK) agreed, upon the completion~~ of ~~the~~2021 ~~Share~~included ~~Sale,~~costs tofor ~~assume~~rebuild ~~the~~and ~~Company’s~~restoration ~~obligation under the Guarantee (proportionately based upon such Purchaser’s percentage acquisition~~ of ~~ordinary shares in the Share Sale). While~~ a ~~formal~~distillation written release of the Company from the Guarantee was not obtained from SIDF prior to closing, the Company believes that the Purchasers’ assumption of the Company’s obligation under the Guarantee effectively eliminates the Company’s liability arising under the Guaranteetower.

~~As the sale of the Company's interest in AMAK was completed as of September 28, 2020, there is no applicable 2021 financial information to present and it is thereby omitted for comparison purposes~~7. LEASES

Included in discontinued operations for 2020 are the following:

	Three Months EndedSeptember 30, 2020		Nine Months EndedSeptember 30, 2020
	(thousands of dollars)
Saudi administration and transaction expenses	$	(2,605)	$	(2,490)
Equity in earnings of AMAK	682		455
Gain on sale of equity interest	28,510		35,173
Income from discontinued operations before taxes	26,587		33,138
Tax expense	(5,263)		(6,959)
Income from discontinued operations, net of tax	$	21,324	$	26,179

AMAK's financial statements were prepared in the functional currency of AMAK which is the SAR. In June 1986, the SAR was officially pegged to the U. S. Dollar at a fixed exchange rate of 1 USD to 3.75 SAR.

Table of Contents 8

The summarized results of operations and financial position for 2020 for AMAK are as follows:

Results of Operations

	Three Months EndedSeptember 30, 2020		Nine Months EndedSeptember 30, 2020
	(thousands of dollars)
Sales	$	23,943	$	62,632
Cost of sales	18,644		53,294
Gross profit	5,299		9,338
Selling, general, and administrative	3,808		8,850
Operating income (loss)	1,491		488
Other income	16		33
Finance and interest expense	(237)		(871)
Income (loss) before Zakat and income taxes	1,270		(350)
Zakat and income tax (benefit)	(240)		859
Net Income (Loss)	$	1,510	$	(1,209)

Financial Position

	December 31, 2020
	(thousands of dollars)
Current assets	$	29,799
Noncurrent assets	209,814
Total assets	$	239,613
Current liabilities	$	40,919
Long term liabilities	79,122
Stockholders' equity	119,572
	$	239,613

The equity in the earnings (losses) of AMAK included in income (loss) from discontinued operations, net of tax, on the condensed consolidated statements of operations for the three and nine months ended September 30, 2020, is comprised of the following:

	Three Months EndedSeptember 30, 2020	Nine Months EndedSeptember 30, 2020
	(thousands of dollars)
AMAK Net Income (Loss)	1,510	(1,209)
Company's share of income (loss) reported by AMAK*	345	(555)
Amortization of difference between Company's investment in AMAK and Company's share of net assets of AMAK	337	1,010
Equity in earnings of AMAK	682	455
* Percentage of Ownership varies during the period.

For additional information, see NOTE 6, “INVESTMENT IN AMAK AND DISCONTINUED OPERATIONS” to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2020.

Table of Contents 9

6. PREPAID EXPENSES AND OTHER ASSETS

Prepaid expenses and other assets consisted of the following:
	September 30, 2021		December 31, 2020
	(thousands of dollars)
Prepaid license	$	—	$	403
Prepaid insurance premiums	2,748		4,241
Spare parts	2,219		2,376
Cash held in escrow by AMAK	—		1,877
Other prepaid expenses and assets	1,676		301
Total prepaid expenses and other assets	$	6,643	$	9,198

7. PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following:
	September 30, 2021		December 31, 2020
	(thousands of dollars)
Platinum catalyst metal	$	1,553	$	1,580
Catalyst	4,325		4,325
Land	5,428		5,428
Plant, pipeline and equipment	280,427		270,149
Construction in progress	8,199		6,422
Total property, plant and equipment	$	299,932	$	287,904
Less accumulated depreciation	(112,365)		(100,800)
Total property, plant and equipment, net	$	187,567	$	187,104

Property, plant and equipment serve as collateral for our amended and restated credit agreement. See Note 11.

Labor capitalized for construction was approximately $0.1 million and $0.1 million for the three months and $0.5 million and $0.1 million for the nine months ended September 30, 2021 and 2020, respectively.

Construction in progress during the first nine months of 2021 included costs for rebuild and restoration of a distillation tower. Construction in progress during the first nine months of 2020 included Advanced Reformer unit improvements and pipeline maintenance at SHR and equipment modifications at TC.

8. LEASES

The Company leases certain rail cars, rail equipment, office space and office equipment. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and accounts for these options when they are reasonably certain of being exercised.

Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets. Lease expense for these leases is recognized on a straight-line basis over the lease term.

The Company has no finance leases.

Table of Contents 10


The components of lease expense were as follows:
($ in thousands)	Classification in the Condensed Consolidated Statements of Income	Three Months Ended March 31,
		2022		2021
Operating lease cost (a)	Cost of sales, exclusive of depreciation and amortization	$	1,164	$	1,049
Operating lease cost (a)	Selling, general and administrative	13		34







Total lease cost		$	1,177	$	1,083

The components of lease expense were as follows:
($ in thousands)	Classification in the Condensed Consolidated Statements of Income	Three Months Ended September 30,				Nine Months EndedSeptember 30,
		2021		2020		2021		2020
Operating lease cost (a)	Cost of sales, exclusive of depreciation and amortization	$	1,124	$	1,115	$	3,132	$	3,036
Operating lease cost (a)	Selling, general and administrative	33		34		102		102
Total lease cost		$	1,157	$	1,149	$	3,234	$	3,138

(a) Short-term lease costs were approximately $0.2 million and $0.2 million for the three months ended March 31, 2022 and 2021, respectively.

(a) Short-term lease costs were approximately $0.2 million and $0.2 million for the three months and $0.5 million and $0.3 million for the nine months ended September 30, 2021 and 2020, respectively.

The Company had no variable lease expense, as defined by ASC 842, during the periods.

($ in thousands)	Classification on the Condensed Consolidated Balance Sheets	September 30, 2021		December 31, 2020
Assets:
Operating	Operating lease assets	$	8,746	$	10,528
Total lease right-of-use assets, net		$	8,746	$	10,528
Liabilities:
Current:
Operating	Current portion of operating lease liabilities	$	3,302	$	3,195
Noncurrent:
Operating	Operating lease liabilities	5,444		7,333
Total lease liabilities		$	8,746	$	10,528


Table of Contents
			7

	Three Months EndedSeptember 30,								Nine Months EndedSeptember 30,
($ in thousands)	Classification on the Condensed Consolidated Balance Sheets		March 31, 2022				December 31, 2021
($ in thousands)	2021				2020				2021		2020
Assets:
Cash paid for amounts included in the measurement of lease liabilities:
Operating	Operating lease assets		$	7,305			$	8,170
Operating cash flows used for operating leases	$	924			$	925			$	2,727	$	2,806
Total lease right-of-use assets, net			$	7,305			$	8,170
Right-of-use assets obtained in exchange for lease obligations:
Liabilities:
Operating leases	$	610			$	37			$	630	$	37
Current:
Operating	Current portion of operating lease liabilities		$	3,085			$	3,227
Noncurrent:
Operating	Operating lease liabilities		4,202				4,923
Total lease liabilities			$	7,287			$	8,150

	September 30, 2021			September 30, 2020
	Three Months EndedMarch 31,
Weighted-average remaining lease term (in years):
($ in thousands)	2022			2021
Operating leases	3.2			3.9
Cash paid for amounts included in the measurement of lease liabilities:
Weighted-average discount rate:
Operating cash flows used for operating leases	$	948		$	903
Operating leases	4.5		%	4.5		%
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	—		$	19


	March 31, 2022		March 31, 2021
Weighted-average remaining lease term (in years):
Operating leases	2.9		3.5

Weighted-average discount rate:
Operating leases	4.5	%	4.5	%

Most of the Company’s lease contracts do not provide a readily determinable implicit rate. For these contracts, the Company’s estimated incremental borrowing rate is based on information available at the inception of the lease.

Table of Contents 11


As of March 31, 2022, maturities of lease liabilities were as follows:
($ in thousands)	Operating Leases
2022	$	2,563
2023	2,619
2024	1,298
2025	1,123
2026	149

Total lease payments	$	7,752
Less: Interest	465
Total lease obligations	$	7,287

As of September 30, 2021, maturities of lease liabilities were as follows:
($ in thousands)	Operating Leases
2021	$	934
2022	3,439
2023	2,547
2024	1,233
2025	1,094
Thereafter	118
Total lease payments	$	9,365
Less: Interest	619
Total lease obligations	$	8,746

8. INTANGIBLE ASSETS, NET

9. INTANGIBLE ASSETS, NET

Intangible assets were recorded in relation to the acquisition of TC on October 1, 2014.

The following tables summarize the gross carrying amounts and accumulated amortization of intangible assets by major class:
	September 30, 2021
	Gross		Accumulated Amortization		Net
	(thousands of dollars)
Customer relationships	$	16,852	$	(7,864)	$	8,988
Non-compete agreements	94		(94)		—
Licenses and permits	1,471		(786)		685
Developed technology	6,131		(4,292)		1,839
Total	$	24,548	$	(13,036)	$	11,512


Table of Contents
			8

December 31, 2020

The following tables summarize the gross carrying amounts and accumulated amortization of intangible assets by major class:

March 31, 2022

Gross

Accumulated Amortization

Net

(thousands of dollars)

Customer relationships

16,852

(78,~~022~~426)

98,~~830~~426

Non-compete agreements

(94)

—

Licenses and permits

1,471

(~~707~~829)

~~764~~642

Developed technology

6,131

(34,~~832~~598)

21,~~299~~533

Total

24,548

(1113,~~655~~947)

1210,~~893~~601

Amortization expense for intangible assets included in cost of sales was approximately $0.5 million and $0.5 million for the three months and $1.4 million and $1.4 million for the nine months ended September 30, 2021 and 2020, respectively.


	December 31, 2021
	Gross		Accumulated Amortization		Net
	(thousands of dollars)
Customer relationships	$	16,852	$	(8,145)	$	8,707
Non-compete agreements	94		(94)		—
Licenses and permits	1,471		(808)		663
Developed technology	6,131		(4,445)		1,686
Total	$	24,548	$	(13,492)	$	11,056

~~Based~~Amortization onexpense ~~identified~~for intangible assets ~~that~~included ~~are~~in ~~subject~~cost toof ~~amortization~~sales aswas ofapproximately ~~September~~$0.5 ~~30,~~million ~~2021,~~and we$0.5 ~~expect~~million ~~future~~for ~~amortization~~the ~~expenses~~three ~~for~~months ~~each~~ended ~~period~~March to31, be2022 asand ~~follows:~~2021, respectively.

	Total		Remainder of 2021		2022		2023		2024		2025		2026		Thereafter
	(thousands of dollars)
Customer relationships	$	8,988	$	281	$	1,123	$	1,123	1,123		1,123		1,123		$	3,092
Licenses and permits	685		22		86		86		86		86		86		233
Developed technology	1,839		153		613		613		460		—		—		—
Total future amortization expense	$	11,512	$	456	$	1,822	$	1,822	$	1,669	$	1,209	$	1,209	$	3,325

Based on identified intangible assets that are subject to amortization as of March 31, 2022, we expect future amortization expenses for each period to be as follows:

Table of Contents 12


	Total		Remainder of 2022		2023		2024		2025		2026		2027		Thereafter
	(thousands of dollars)
Customer relationships	$	8,426	$	843	$	1,123	$	1,123	1,123		1,123		1,123		$	1,968

Licenses and permits	642		64		86		86		86		86		86		148
Developed technology	1,533		460		613		460		—		—		—		—
Total future amortization expense	$	10,601	$	1,367	$	1,822	$	1,669	$	1,209	$	1,209	$	1,209	$	2,116

109. ACCRUED LIABILITIES

Accrued liabilities consisted of the following:

September 30, 2021

December 31, 2020

March 31, 2022

December 31, 2021

(thousands of dollars)

State taxes

~~107~~288

~~125~~192

Property taxes

~~2,347~~760

—

Payroll

21,~~653~~179

21,~~282~~406

Royalties

~~143~~454

~~260~~294

Officer compensation

1,134

1,053

Incentive compensation

3,168

3,508

Legal

~~1,384~~165

—

AMAK foreign taxes and transaction costs

—

1,613

Professional expenses

—

287

Other

31,~~276~~109

~~1,524~~186

Total accrued liabilities

117,~~044~~123

65,~~857~~873

~~11.~~Table ~~LIABILITIES~~of ~~AND~~Contents ~~LONG-TERM DEBT~~9

10. LIABILITIES AND LONG-TERM DEBT

Senior Secured Credit Facilities

As of ~~September~~March 3031, ~~2021~~2022, the Company had no outstanding borrowings under the senior secured revolving credit facility (the “Revolving Facility”) and approximately $4240.9 million in borrowings outstanding under the senior secured term loan facility (the “Term Loan Facility”) (and, together with the Revolving Facility, the “Credit Facilities”), in each case, under the Company's amended and restated credit agreement (as amended, the “ARC Agreement”). In addition, the Company had approximately $75 million of availability under our Revolving Facility at ~~September~~March 3031, ~~2021~~2022. TOCCO’s ability to make additional borrowings under the Revolving Facility at ~~September~~March 3031, ~~2021~~2022 was limited by, and in the future may be limited by, the Company's obligation to maintain compliance with the covenants contained in the ARC Agreement (including maintenance of a maximum Consolidated Leverage Ratio and minimum Consolidated Fixed Charge Coverage Ratio (each as defined in the ARC Agreement)).

OnFor ~~May~~each 3,fiscal ~~2021,~~quarter ~~TOCCO,~~after ~~SHR~~December 31, ~~GSPL and TC (SHR~~2019, ~~GSPL~~TOCCO ~~and~~must TCmaintain ~~collectively,~~a ~~the~~maximum ~~"Guarantors")~~Consolidated ~~entered~~Leverage ~~into~~Ratio anof ~~Eighth~~3.50 ~~Amendment~~ to ~~Amended~~1.00 ~~and~~(subject ~~Restated~~to ~~Credit~~temporary ~~Agreement~~increase ~~(the~~following ~~“Eighth~~certain ~~Amendment”~~acquisitions). ~~which~~TOCCO's ~~amended the definition of~~ Consolidated ~~EBITDA~~Leverage ~~for~~Ratio ~~any~~was ~~Measurement~~1.20 ~~Period~~and (1.24 as ~~defined~~of inMarch ~~the~~31, ~~ARC~~2022 ~~Agreement)~~and ~~(including~~December ~~any Measurement Period containing the quarter ended March~~ 31, 2021), torespectively. ~~allow~~Additionally, ~~for~~TOCCO ~~certain~~must ~~add~~maintain ~~backs~~a ~~not~~minimum toConsolidated ~~exceed~~Fixed ~~$5.0 million~~Charge inCoverage ~~the~~Ratio ~~aggregate~~as ~~for~~of the ~~2021~~end ~~fiscal~~of ~~year~~any ~~related~~fiscal toquarter ~~charges,~~of ~~expenses~~1.15 ~~and~~to ~~losses~~1.00. ~~arising~~TOCCO's ~~from~~Consolidated orFixed ~~related~~Charge toCoverage ~~the~~Ratio ~~prolonged~~was ~~period~~3.43 ~~of sub-freezing temperatures~~ and ~~snow~~3.65 ~~across~~as ~~the~~of ~~State~~March of31, ~~Texas~~2022 and ~~the~~December ~~region~~31, ~~in February~~ 2021, ~~(the “Texas freeze event”)~~respectively.

~~For~~The ~~each~~maturity ~~fiscal~~date ~~quarter~~for ~~after~~the ~~December~~ARC ~~31,~~Agreement ~~2019,~~is ~~TOCCO~~July ~~must~~31, ~~maintain~~2023. aAs ~~maximum~~of ~~Consolidated~~March ~~Leverage~~31, ~~Ratio~~2022, ofthe ~~3.50~~year to ~~1.00~~date ~~(subject~~effective tointerest ~~temporary~~rate ~~increase~~for ~~following~~the ~~certain~~Credit ~~acquisitions).~~Facilities ~~TOCCO's Consolidated Leverage Ratio~~ was 1.~~20 and 1~~89%.34 asThe ofARC ~~September~~Agreement ~~30,~~contains ~~2021 and June 30, 2021, respectively. Additionally, TOCCO must maintain~~ a ~~minimum~~number ~~Consolidated~~of ~~Fixed~~customary ~~Charge~~affirmative ~~Coverage~~and ~~Ratio~~negative ascovenants ofand the ~~end~~Company ofwas ~~any~~in ~~fiscal~~compliance ~~quarter~~with ofthose ~~1.15~~covenants ~~to 1.00. TOCCO's Consolidated Fixed Charge Coverage Ratio was 2.95 and 3.07~~ as of ~~September~~March ~~30, 2021 and December~~ 31, ~~2020, respectively~~2022.

~~The~~For ~~maturity~~a ~~date~~summary ~~for~~of ~~the~~additional ~~ARC~~terms ~~Agreement is July 31, 2023. As~~ of ~~September 30, 2021,~~ the ~~year to date effective interest rate for the~~ Credit Facilities, ~~was~~see ~~1.86%.~~NOTE ~~The~~13, ~~ARC~~“LONG-TERM ~~Agreement~~DEBT ~~contains~~AND aLONG-TERM ~~number~~OBLIGATIONS” ofto ~~customary~~the ~~affirmative~~consolidated ~~and~~financial ~~negative~~statements ~~covenants~~set ~~and~~forth ~~the Company was~~ in ~~compliance~~the ~~with~~Annual ~~those~~Report ~~covenants~~on asForm ~~of September 30~~10-K, ~~2021~~as amended.

For a summary of additional terms of the Credit Facilities, see NOTE 13, “LONG-TERM DEBT AND LONG-TERM OBLIGATIONS” to the consolidated financial statements set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.

PPP Loans

On May 6, 2020, SHR and TC (collectively, the “Borrowers”) received loan proceeds from loans (the “PPP Loans”) under the United States Small Business Administration Paycheck Protection Program in an aggregate principal amount of approximately $6.1 million. The PPP Loans are evidenced by unsecured promissory notes each payable to Bank of America, N.A. The Borrowers fully utilized the PPP Loans to cover payroll and benefits costs in accordance with the relevant terms and conditions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loans mature on May 6, 2022, and bear interest at a stated rate of 1.0% per annum. The Company filed a forgiveness application for SHR on June 30, 2021 and for TC on July 26, 2021. On September 8, 2021, the Company was notified of full forgiveness for the PPP

Table of Contents 13

Loan for TC of approximately $2.2 million. This is recognized as gain on extinguishment of debt in the financial statements. The Company expects to receive full forgiveness of the SHR PPP Loan in accordance with the provisions of the CARES Act.

Debt Issuance Costs

Debt issuance costs of approximately $0.9 million were incurred in connection with the fourth amendment to the ARC Agreement in July 2018. Unamortized debt issuance costs of approximately $0.32 million and $0.53 million ~~for~~as ~~the~~of ~~periods~~March ~~ended September 30~~31, ~~2021~~2022 and December 31, ~~2020~~2021, respectively, have been netted against outstanding loan balances.

Long-term debt and long-term obligations are summarized as follows:
	September 30, 2021		December 31, 2020
	March 31, 2022		December 31, 2021
	(thousands of dollars)
Revolving Facility	$	—	$	—
Term Loan Facility	4341,~~281~~094		4642,~~563~~188
Loan fees	(~~332~~242)		(~~468~~287)
Total long-term debt	4240,~~949~~852		4641,~~095~~901
Less current portion including loan fees	4,194		4,194
Total long-term debt, less current portion including loan fees	$	3836,~~755~~658	$	4137,~~901~~707

1211. COMMITMENTS AND CONTINGENCIES

Litigation

The Company is periodically named in legal actions arising from normal business activities. We evaluate the merits of these actions and, if we determine that an unfavorable outcome is probable and can be reasonably estimated, we will establish the necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.

Supplier Agreements

In accordance with our supplier agreements, on a recurring monthly basis, the Company commits to purchasing a determined volume of feedstock in anticipation of upcoming requirements. Feedstock purchases are invoiced and recorded when they are delivered. As of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021, the value of the remaining undelivered feedstock approximated $1828.03 million and $919.27 million, respectively.

~~From~~Table ~~time~~of toContents time, we may incur shortfall fees due to feedstock purchases being below the minimum amounts prescribed by our agreements with our suppliers. Shortfall fee expenses were approximately $0.4 million and $0.2 million for the three months and $0.8 million and $1.2 million for the nine months ended September 30, 2021 and 2020, respectively.10

From time to time, we may incur shortfall fees due to feedstock purchases being below the minimum amounts prescribed by our agreements with our suppliers. Shortfall fee expenses were approximately $0.2 million and $0.4 million for the three months ended March 31, 2022 and 2021, respectively.

Environmental Remediation

Amounts charged to expense for various activities related to environmental monitoring, compliance, and improvements were approximately $0.31 million and $0.23 million for the three months ~~and $0.9 million and $0.7 million for the nine months~~ ended ~~September~~March 3031, ~~2021~~2022 and ~~2020~~2021, respectively.

1312. STOCKHOLDERS' EQUITY

In March 2021, the Company’s Board of Directors authorized the repurchase of up to $20 million in common stock by March 2023 (the “Share Repurchase Program”). The share repurchases will be executed from time to time on the open market, through privately negotiated transactions or through broker-negotiated purchases, in compliance with applicable securities law. The timing and amount of any shares of the Company’s stock that are repurchased under the Share Repurchase Program will be determined by the Company’s management based on its evaluation of market conditions and other factors, including the Company’s stock price, although the Share Repurchase Program may be suspended or discontinued at any time. InThe ~~connection~~Company ~~with~~repurchased ~~the~~no ~~Share~~shares ~~Repurchase~~during ~~Program,~~ the ~~Company~~three ~~deposited~~months ~~funds~~ended ~~with~~March a31, ~~broker~~2022 toand ~~facilitate~~2021, ~~the repurchases~~respectively. ~~The~~As ~~Company~~of ~~repurchased~~March no31, ~~shares~~2022, ~~during~~ the ~~three~~value ~~months~~of ~~and~~shares ~~633,273~~that ~~shares~~may ~~for~~yet ~~approximately~~be ~~$5.0 million~~purchased ~~during~~under the ~~nine~~Share ~~months~~Repurchase ~~ended~~Program ~~September~~is ~~30,~~approximately ~~2021,~~$8.8 ~~respectively~~million.

1413. STOCK-BASED COMPENSATION

The Stock Option Plan for Key Employees, as well as, the Non-Employee Director Stock Option Plan (hereinafter collectively referred to as the “Stock Option Plans”), were approved by the Company’s stockholders in July 2008. The Stock Option Plans allot for the issuance of up to 1,000,000 shares.

Table of Contents 14

The Trecora Resources Stock and Incentive Plan (the “Plan”) was approved by the Company’s stockholders in June 2012. As amended, the Plan allots for the issuance of up to 2.5 million shares in the form of stock options or restricted stock unit awards.

The Company recognized stock-based compensation expense of approximately $0.65 million and $0.56 million for the three months ~~and $1.7 million and $1.4 million for the nine months~~ ended ~~September~~March 3031, ~~2021~~2022 and ~~2020~~2021, respectively.

Stock ~~Options~~Option ~~and Warrant~~ Awards

~~Stock~~Awards ~~options and warrants~~ granted under the provisions of the Stock Option Plans permit the purchase of our common stock at exercise prices equal to the closing price of Company common stock on the date the options were granted. The options have terms of 10 years and generally vest ratably over terms of 4 to 5 years. There were no ~~stock options or warrant~~ awards issued during the three ~~or nine~~ months ended ~~September~~March 3031, ~~2021~~2022 or ~~2020~~2021, respectively.

A summary of the status of the Company’s ~~stock option and warrant~~ awards is as follows:

	Stock Options and Warrants	Weighted Average Exercise Price Per Share	Weighted Average Remaining Contractual Life	IntrinsicValue(in thousands)
	Stock Option Awards	Weighted Average Exercise Price Per Share	Weighted Average Remaining Contractual Life	IntrinsicValue(in thousands)
Outstanding at January 1, 2021	487,000	10.87
Outstanding at January 1, 2022	467,000	11.16
Granted	—	—
Exercised	~~(20,000)~~—	~~4.09~~—
Forfeited	—	—
Outstanding at September 30, 2021	467,000	11.16	2.1	$	—
Outstanding at March 31, 2022	467,000	11.16	1.6	$	—
Expected to vest	—			$	—
Exercisable at September 30, 2021	467,000	11.16	2.1	$	—
Exercisable at March 31, 2022	467,000	11.16	1.6	$	—

The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At ~~September~~March 3031, ~~2021~~2022, options to purchase approximately 0.1 million shares of common stock were in-the-money.

Since no ~~options~~awards were granted, the weighted average grant-date fair value per share of ~~options~~awards granted during the three ~~and nine~~ months ended ~~September~~March 3031, ~~2021~~2022 and ~~2020~~2021, respectively, was zero.

~~The~~Table ~~Company has no non-vested outstanding options as~~ of ~~September~~Contents ~~30, 2021.~~11

The Company has no non-vested outstanding awards as of March 31, 2022.

Restricted Stock Unit Awards

Generally, restricted stock unit awards are granted annually to officers and directors of the Company under the provisions of the Plan. Restricted stock units are also granted ad hoc to attract or retain key personnel, and the terms and conditions under which these restricted stock units vest vary by award. The fair market value of restricted stock units granted is equal to the Company’s closing stock price on the date of grant. Restricted stock units granted to directors ~~vest~~have ~~ratably over~~ a 1one year vesting period, while restricted stock units granted to officers generally vest ratably over 3 years. Certain awards also include vesting provisions based on performance metrics measured over a 3 year period. Upon vesting, the restricted stock units are settled by issuing one share of the Company's common stock per unit.

A summary of the status of the Company's restricted stock units activity is as follows:
	Shares of Restricted Stock Units	Weighted Average Grant Date Price per Share
Outstanding at January 1, 2021	567,563	7.39
Outstanding at January 1, 2022	586,444	7.32
Granted	~~337~~194,~~443~~266	78.3078
Forfeited	(~~121~~37,~~448~~058)	79.9823
Vested	(~~172~~126,~~114~~823)	78.6579
Outstanding at September 30, 2021	611,444	7.40
Outstanding at March 31, 2022	616,829	7.57
Expected to vest	~~611~~616,~~444~~829

1514. INCOME TAXES

We file an income tax return in the U.S. federal jurisdiction and a margin tax return in Texas. Previously, the Texas Comptroller selected the R&D credit calculations related to the 2014 and 2015 calendar years for audit. The state of Texas suspended examination of the 2014 and 2015 calendar years in order to perform a comprehensive review of audit procedures to provide consistency. During the fourth quarter of 2019, we received notice that Texas had completed review of its procedures and initiated additional requests for information which has been submitted for their review. We do not expect any material changes related to the Texas audits. Our federal and Texas tax returns remain open for examination for the years 2017 through 2020. As of March 31, 2022 and December 31, 2021, respectively, we recognized no adjustments for uncertain tax positions or related interest and penalties.

~~Table~~The effective tax rate varies from the federal statutory rate of ~~Contents~~21%, 15primarily as a result of stock based compensation, state tax expense and other permanent items for the three months ended March 31, 2022 and 2021.

~~suspended examination of the 2014 and 2015 calendar years in order to perform a comprehensive review of audit procedures to provide consistency~~15. ~~During~~SEGMENT the fourth quarter of 2019, we received notice that Texas had completed review of its procedures and initiated additional requests for information which has been submitted for their review. We do not expect any material changes related to the Texas audits. Our federal and Texas tax returns remain open for examination for the years 2017 through 2020. As of September 30, 2021 and December 31, 2020, respectively, we recognized no adjustments for uncertain tax positions or related interest and penalties.INFORMATION

The effective tax rate varies from the federal statutory rate of 21%, primarily as a result of foreign tax credits, state tax expense and stock based compensation for the nine months ended September 30, 2021 and 2020. We continue to maintain a valuation allowance against certain deferred tax assets, specifically for mining claims for PEVM, where realization is not certain.

The CARES Act provided stimulus measures to companies impacted by the COVID-19 pandemic, which included the ability to defer payment for employer payroll taxes, utilize net operating loss (“NOL”) carrybacks, increased the limitation on the deductibility of interest expense, technical corrections to allow accelerated tax depreciation on qualified improvement property, as well as allowing qualified business to apply for loans and grants. We filed carryback claims allowed under these provisions and have collected all amounts, including interest. The remaining approximately $2.5 million related to our second and final NOL carryback claims, including approximately $0.1 million of interest income, was received in April 2021.

16. SEGMENT INFORMATION

We operate through business segments according to the nature and economic characteristics of our products as well as the manner in which the information is used internally by our key decision maker, who is our Chief Executive Officer. Segment data may include rounding differences.

Our Specialty Petrochemicals segment includes SHR and GSPL. Our Specialty Waxes segment is TC. We also separately identify our corporate overhead which includes administrative activities such as legal, accounting, consulting, investor relations, officer and director compensation, corporate insurance, and other administrative costs.

	Three Months Ended September 30, 2021
	Specialty Petrochemicals		Specialty Waxes		Corporate		Consolidated
	(in thousands)
Product sales	$	61,938	$	8,484	$	—	$	70,422
Processing fees	1,419		2,796		—		4,215
Total revenues	63,357		11,280		—		74,637
Operating income (loss) before depreciation and amortization	7,258		2,041		(4,953)		4,346
Operating income (loss)	4,413		489		(5,069)		(167)
Income (loss) from continuing operations before taxes	4,062		2,671		(5,061)		1,672
Depreciation and amortization	2,844		1,553		—		4,397
Capital expenditures	3,416		215		—		3,631


Table of Contents
			12

Three Months Ended September 30, 2020

Three Months Ended March 31, 2022

Specialty Petrochemicals

Specialty Waxes

Corporate

Consolidated

(in thousands)

Product sales

3769,~~580~~090

59,~~990~~971

—

4379,~~570~~061

Processing fees

1,~~644~~488

2,~~533~~665

—

4,~~177~~153

Total revenues

3970,~~224~~578

812,~~523~~636

—

4783,~~747~~214

Operating income (loss) before depreciation and amortization

85,~~538~~378

891,909

(2,~~050~~854)

64,~~577~~433

Operating income (loss)

52,~~871~~654

~~(1,337)~~331

(2,~~052~~853)

~~2,482~~132

Income (loss) from continuing operations before taxes

5,311

(1,293)

(2,057)

1,961

Income (loss) before taxes

2,362

324

(2,768)

(82)

Depreciation and amortization

2,~~667~~729

1,~~427~~578

2—

4,~~096~~307

Capital expenditures

24,~~084~~129

~~641~~722

—

24,~~725~~851

Table of Contents 16


	Three Months Ended March 31, 2021
	Specialty Petrochemicals		Specialty Waxes		Corporate		Consolidated
	(in thousands)
Product sales	$	44,658	$	6,907	$	—	$	51,565
Processing fees	1,254		1,766		—		3,020
Total revenues	45,912		8,673		—		54,585
Operating income (loss) before depreciation and amortization	2,571		(481)		(3,023)		(933)
Operating income (loss)	(231)		(1,957)		(3,025)		(5,213)
Income (loss) before taxes	(297)		(1,954)		(3,154)		(5,405)
Depreciation and amortization	2,802		1,476		3		4,281
Capital expenditures	3,567		1,214		—		4,781

	Nine Months Ended September 30, 2021
	March 31, 2022
	Specialty Petrochemicals		Specialty Waxes		Corporate		Eliminations	Consolidated
	(in thousands)
Product sales	$	164,359	$	22,288	$	—		$	186,647
Intangible assets, net	—		10,601		—		—	10,601
Processing fees	4,200		7,224		—			11,424
Total assets	293,854		79,953		109,853		(190,465)	293,195
Total revenues	168,559		29,512		—			198,071
Operating income (loss) before depreciation and amortization	19,570		2,881		(11,973)			10,478
Operating income (loss)	11,137		(1,666)		(11,729)			(2,258)
Income (loss) from continuing operations before taxes	10,474		533		(11,782)			(775)
Depreciation and amortization	8,433		4,547		6			12,986
Capital expenditures	10,675		1,620		—			12,295

	Nine Months Ended September 30, 2020
	December 31, 2021
	Specialty Petrochemicals		Specialty Waxes		Corporate		Eliminations	Consolidated
	(in thousands)
Product sales	$	119,202	$	18,258	$	—		$	137,460
Intangible assets, net	—		11,056		—		—	11,056
Processing fees	4,047		8,981		—			13,028
Total assets	298,966		79,860		109,292		(194,578)	293,540
Total revenues	123,249		27,239		—			150,488
Operating income (loss) before depreciation and amortization	20,002		2,009		(6,665)			15,346
Operating income (loss)	12,097		(2,084)		(6,677)			3,336
Income (loss) from continuing operations before taxes	9,901		(1,980)		(6,751)			1,170
Depreciation and amortization	7,905		4,093		13			12,011
Capital expenditures	9,067		1,242		—			10,309

	September 30, 2021
	Specialty Petrochemicals	Specialty Waxes	Corporate	Eliminations	Consolidated
	(in thousands)
Intangible assets, net	—	11,512	—	—	11,512
Total assets	298,885	81,477	118,986	(191,543)	307,805

16. NET INCOME (LOSS) PER COMMON SHARE

	December 31, 2020
	Specialty Petrochemicals	Specialty Waxes	Corporate	Eliminations	Consolidated
	(in thousands)
Intangible assets, net	—	12,893	—	—	12,893
Total assets	298,198	83,108	127,260	(191,733)	316,833

The following tables set forth the computation of basic and diluted net income (loss) per share for the three months ended March 31, 2022 and 2021, respectively.

~~17.~~Table ~~NET~~of ~~INCOME~~Contents ~~(LOSS) PER COMMON SHARE~~13

The following tables set forth the computation of basic and diluted net income (loss) per share for the three and nine months ended September 30, 2021 and 2020, respectively.


	Three Months Ended March 31, 2022					Three Months Ended March 31, 2021
	Loss		Shares	Per Share Amount		Loss		Shares	Per Share Amount
	(in thousands, except per share amounts)
Basic:
Net loss	$	(376)	23,600	$	(0.02)	$	(4,404)	24,861	$	(0.18)


Diluted:
Net loss	$	(376)	23,600	$	(0.02)	$	(4,404)	24,861	$	(0.18)

~~Table~~At March 31, 2022 and 2021, approximately 0.6 million and 0.7 million shares of ~~Contents~~unvested 17restricted stock units, respectively, were not included in the computation of diluted earnings per share because such restricted stock units would be anti-dilutive.

~~Net~~At ~~Income~~March ~~(Loss)~~31, 2022 and 2021, 0.5 million and 0.7 million shares of common stock, respectively, were issuable upon the exercise of outstanding stock options and were not included in the computation of diluted earnings per ~~Common~~share ~~Share~~because -such ~~Continuing~~options ~~Operations~~would be anti-dilutive.

	Three Months EndedSeptember 30, 2021					Three Months EndedSeptember 30, 2020
	Income		Shares	Per ShareAmount		Income		Shares	Per ShareAmount
	(in thousands, except per share amounts)
Basic:
Net income from continuing operations	$	1,883	24,341	$	0.08	$	1,108	24,817	$	0.04
Unvested restricted stock units			611					577
Diluted:
Net income from continuing operations	$	1,883	24,952	$	0.08	$	1,108	25,394	$	0.04
	Nine Months EndedSeptember 30, 2021					Nine Months EndedSeptember 30, 2020
	Loss		Shares	Per ShareAmount		Income		Shares	Per ShareAmount
	(in thousands, except per share amounts)
Basic:
Net income (loss) from continuing operations	$	(266)	24,562	$	(0.01)	$	5,112	24,795	$	0.21
Unvested restricted stock units			—					384
Diluted:
Net income (loss) from continuing operations	$	(266)	24,562	$	(0.01)	$	5,112	25,179	$	0.20

Table of Contents 18

Net Income (Loss) per Common Share - Discontinued Operations

	Three Months EndedSeptember 30, 2021					Three Months EndedSeptember 30, 2020
	Income		Shares	Per ShareAmount		Income		Shares	Per ShareAmount
	(in thousands, except per share amounts)
Basic:
Net income from discontinued operations, net of tax	$	—	24,341	$	—	$	21,324	24,817	$	0.86
Unvested restricted stock units			611					577
Diluted:
Net income from discontinued operations, net of tax	$	—	24,952	$	—	$	21,324	25,394	$	0.84
	Nine Months EndedSeptember 30, 2021					Nine Months EndedSeptember 30, 2020
	Income		Shares	Per ShareAmount		Income		Shares	Per ShareAmount
	(in thousands, except per share amounts)
Basic:
Net income from discontinued operations, net of tax	$	—	24,562	$	—	$	26,179	24,795	$	1.06
Unvested restricted stock units			—					384
Diluted:
Net income from discontinued operations, net of tax	$	—	24,562	$	—	$	26,179	25,179	$	1.04

Net Income (Loss) per Common Share

	Three Months EndedSeptember 30, 2021					Three Months EndedSeptember 30, 2020
	Income		Shares	Per ShareAmount		Income		Shares	Per ShareAmount
	(in thousands, except per share amounts)
Basic:
Net income	$	1,883	24,341	$	0.08	$	22,432	24,817	$	0.90
Unvested restricted stock units			611					577
Diluted:
Net income	$	1,883	24,952	$	0.08	$	22,432	25,394	$	0.88
	Nine Months EndedSeptember 30, 2021					Nine Months EndedSeptember 30, 2020
	Loss		Shares	Per ShareAmount		Income		Shares	Per ShareAmount
	(in thousands, except per share amounts)
Basic:
Net income (loss)	$	(266)	24,562	$	(0.01)	$	31,291	24,795	$	1.27
Unvested restricted stock units			—					384
Diluted:
Net income (loss)	$	(266)	24,562	$	(0.01)	$	31,291	25,179	$	1.24

At September 30, 2021 and 2020, 0.5 million and 0.5 million shares of common stock, respectively, were issuable upon the exercise of options and warrants.

Table of Contents 19

18. RELATED PARTY TRANSACTIONS

In November 2020, Company Director Adam C. Peakes joined Merichem Company as Executive Vice President and Chief Financial Officer. The Company incurred expenses of less than $0.1 million during the three and nine months ended September 30, 2021 and 2020, respectively, for Merichem Company. At September 30, 2021 and December 31, 2020, we had outstanding liabilities payable to Merichem Company of less than $0.1 million and nil, respectively.

19. POST-RETIREMENT OBLIGATIONS

We currently have post-retirement obligations with two former executives. As of September 30, 2021 and December 31, 2020, approximately $0.3 million and $0.3 million, respectively, remained outstanding and was included in post-retirement obligations.

For additional information, see NOTE 22, “POST-RETIREMENT OBLIGATIONS” to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2020.

Table of Contents 20

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

FORWARD LOOKING AND CAUTIONARY STATEMENTS

Some of the statements and information contained in this Quarterly Report on Form 10-Q may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements regarding the Company’s financial position, business strategy and plans and objectives of the Company’s management for future operations and other statements that are not historical facts, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as “outlook,” “may,” “will,” “can,” “shall,” “should,” “could,” “expects,” “plans,” “anticipates,” “contemplates,” “proposes,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “continue,” “intend,” or the negative of such terms and other comparable terminology, or by discussions of strategy, plans or intentions.

Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other important factors that could cause the actual results, performance or our achievements, or industry results, to differ materially from historical results, any future results, or performance or achievements expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to the impacts of the COVID-19 pandemic on our business, financial results and financial condition and that of our customers, suppliers, and other counterparties; general economic and financial conditions domestically and internationally including the impact of rising inflation and supply chain issues; the ongoing impact of geopolitical conflict; the impact of actions by activist stockholders; insufficient cash flows from operating activities; our ability to attract and retain key employees; feedstock and product prices; feedstock availability and our ability to access third party transportation; competition; industry cycles; natural disasters or other severe weather events ~~(such as the Texas freeze event)~~, health epidemics and pandemics (including the COVID-19 pandemic) and terrorist attacks; our ability to consummate, and the costs associated with, extraordinary transactions, including acquisitions, dispositions and other ~~strategic~~business ~~initiatives~~combinations, and realize the financial and strategic goals of such transactions; technological developments and our ability to maintain, expand and upgrade our facilities; regulatory changes; environmental matters; lawsuits; outstanding debt and other financial and legal obligations ~~(including having to return the amounts borrowed under the PPP Loans or failing to qualify for forgiveness of such loans, in whole or in part)~~; difficulties in obtaining additional financing on favorable conditions, or at all; local business risks in foreign countries, including civil unrest and military or political conflict, local regulatory and legal environments and foreign currency fluctuations; and other risks detailed in ~~our~~the ~~latest~~ Annual Report on Form 10-K, as amended, including, but not limited to, “Part I, Item 1A. Risk Factors” and “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” therein, under similar headings in this Quarterly Report on Form 10-Q and in our other filings with the Securities and Exchange Commission (the “SEC”). Many of these risks and uncertainties are currently amplified by and will continue to be amplified by, or in the future may be amplified by, the COVID-19 pandemic and other natural disasters such as severe weather events.

There may be other factors of which we are currently unaware or deem immaterial that may cause our actual results to differ materially from the forward-looking statements. In addition, to the extent any inconsistency or conflict exists between the information included in this report and the information included in our prior releases, reports and other filings with the SEC, the information contained in this report updates and supersedes such information.


Table of Contents
			14

Forward-looking statements are based on current plans, estimates, assumptions and projections, and, therefore, you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them in light of new information or future events.

Overview

The following discussion and analysis of our financial results, as well as the accompanying unaudited condensed consolidated financial statements and related notes to condensed consolidated financial statements to which they refer, are the responsibility of our management. Our accounting and financial reporting fairly reflect our business model which is based on the manufacturing and marketing of specialty petrochemical products and waxes and providing custom manufacturing services.

The discussion and analysis of financial condition and the results of operations which appears below should be read in conjunction with “Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations” of ~~our~~the Annual Report on Form 10-K ~~for the year ended December 31~~, ~~2020.~~as ~~These discussions of results reflect the continuing operations of the Company unless otherwise noted~~amended.

Our preferred supplier position into the specialty petrochemicals market is derived from the combination of our reputation as a reliable supplier established over many years, the very high purity of our products, and a focused approach to customer service. In specialty waxes, we are able to deliver to our customers a product performance and price point that we believe is unique to our market; while the diversity of our custom processing assets and capabilities offers solutions to our customers that we believe are uncommon along the U.S. Gulf Coast. The specialty waxes business also delivers environmental circularity by using proprietary technology to convert waste products generated by suppliers' polyethylene production to high value solutions for our customers.

~~Table~~Enabling our success in these businesses is a commitment to operational excellence which establishes a culture that prioritizes the safety of ~~Contents~~our 21employees and communities in which we operate, the integrity of our assets and regulatory compliance. This commitment drives a change to an emphasis on forward-looking, leading-indicators of our results and proactive steps to continuously improve our performance. We bring the same commitment to excellence to our commercial activities where we focus on the value proposition to our customers while understanding opportunities to maximize our value capture through service and product differentiation, supply chain and operating cost efficiencies and diversified supply options. We believe our focus on execution, meeting the needs of our customers, and growing our business while maintaining prudent control of our costs, will significantly contribute to enhanced stockholder value.

~~Enabling~~Review ~~our success in these businesses is a commitment to operational excellence which establishes a culture that prioritizes the safety~~ of ~~our~~First ~~employees~~Quarter ~~and~~2022 communities in which we operate, the integrity of our assets and regulatory compliance. This commitment drives a change to an emphasis on forward-looking, leading-indicators of our results and proactive steps to continuously improve our performance. We bring the same commitment to excellence to our commercial activities where we focus on the value proposition to our customers while understanding opportunities to maximize our value capture through service and product differentiation, supply chain and operating cost efficiencies and diversified supply options. We believe our focus on execution, meeting the needs of our customers, and growing our business while maintaining prudent control of our costs, will significantly contribute to enhanced shareholder value.Results

~~Review~~We reported first quarter 2022 net loss of ~~Third~~approximately ~~Quarter~~$0.4 million, an increase from net loss of $4.4 million in the first quarter of 2021. ~~Results~~Sales volume of our Specialty Petrochemicals products increased 17.6% in the first quarter of 2022 as compared to the first quarter of 2021. Specialty Waxes sales revenue was up 44.4% compared to the first quarter 2021. First quarter 2022 results improved primarily due to increased pricing, the ongoing economic recovery and stronger demand from our end-use markets. Our first quarter 2021 results were significantly impacted by the prolonged period of sub-freezing temperatures and snow across the State of Texas and the region in February 2021 (the “Texas freeze event”) including reduced demand and higher natural gas and transportation costs.

WeAdjusted ~~reported~~EBITDA ~~third~~was ~~quarter~~$5.8 ~~2021~~million ~~net~~for ~~income~~the ~~from~~first ~~continuing~~quarter ~~operations~~ of ~~approximately $1.9 million~~2022, ancompared ~~increase~~with ~~from~~Adjusted ~~net~~EBITDA ~~income from continuing operations~~ of $1(0.1) million in the ~~third~~first quarter of ~~2020~~2021. ~~Sales~~Adjusted ~~volume~~EBITDA ofincreased ~~our~~due ~~Specialty~~to ~~Petrochemicals products~~ increased ~~16.8%~~selling inprices ~~the~~and ~~third~~sales ~~quarter~~volumes. ofAdditionally, ~~2021 as compared to~~ the ~~third~~first quarter of ~~2020.~~2021 ~~Specialty Waxes sales revenue~~ was upimpacted ~~41.6%~~by ~~compared to~~ the ~~third~~Texas ~~quarter~~freeze ~~2020~~event. ~~Third~~As ~~quarter~~previously ~~2021~~disclosed, ~~results~~the ~~continued~~Company tooriginally ~~improve~~estimated ~~due to~~ the ~~ongoing~~negative ~~economic~~impact ~~recovery~~of ~~and~~the ~~stronger~~Texas ~~demand~~freeze ~~from~~event ~~our~~to ~~end-use~~be ~~markets~~approximately $5.0 ~~However,~~million ~~our~~for ~~third quarter 2021 results include~~ the ~~negative~~first ~~impacts~~quarter of ~~higher~~2021. ~~natural~~This ~~gas~~estimate ~~and~~was ~~transportation~~subsequently ~~costs,~~reduced asto ~~well~~$3.5 asmillion ~~continued~~in ~~supply-chain~~the ~~disruptions.~~second ~~Third~~ quarter ~~2020~~of ~~results~~2021 ~~were generally weaker~~ due to ~~the~~a ~~impact~~settlement agreement of ~~the~~$1.4 ~~COVID-19~~million ~~pandemic~~with ona ~~end-use~~utility ~~markets and our customers~~provider.

Adjusted EBITDA from continuing operations was $7.5 million for the third quarter of 2021, compared with Adjusted EBITDA from continuing operations of $7.1 million in the third quarter of 2020. Adjusted EBITDA from continuing operations increased due to increased sales volumes and selling prices. The third quarter of 2020 was impacted by the COVID-19 pandemic. See below for additional information about this measure and a reconciliation to the most directly comparable GAAP financial measure.

COVID-19 Pandemic

The continued global impact of COVID-19 has resulted in various emergency measures to combat the spread of the virus. With the development of variants and increased vaccination rates, the status of ongoing measures varies widely depending on the country and locality. We continue to monitor the progression of the COVID-19 pandemic on a daily basis. Our guiding principle is, and has always been, the protection of our people and the communities in which we work, as well as maintaining the overall integrity of our assets. We are continuing to follow the orders and guidance of federal, state, and local governmental agencies, as we maintain our own stringent protocols in an effort to mitigate the spread of the virus and protect the health of our employees, customers, and suppliers as well as the communities in which we work. As an organization, we adopted social distancing behaviors early, executed the necessary changes to enable all possible job duties to be performed remotely and rapidly identified and executed the necessary adjustments to support optimal productivity for all remote workers.

To date, our plants have continued to operate normally with regard to COVID-19, and our supply chain has generally remained intact, with adequate availability of raw materials. Importantly, under the U.S. Department of Homeland Security guidance issued on April 17, 2020 as updated through August 18, 2020, as well as many related state and local governmental orders, chemical manufacturing sites are considered essential critical infrastructure, and as such, have not been subject to closure in the locations where we operate. However, there have been widespread disruption in global logistics channels and we have experienced some delays in fulfillment of export customer orders.

As an organization, since the start of 2021, we have encouraged our workforce to receive vaccinations against COVID-19 through various means including incentive programs and an on-site vaccination event. However, new variants, particularly the Delta variant, have engendered a resurgence of the virus in many regions. In the midst of changing conditions, we have nevertheless been able to continue to manage our business with minimal impact as we have throughout the COVID-19 pandemic. With improving vaccination rates, we have also recently reopened some of our offices to flex schedule staffing for administrative employees.

Through the third quarter of 2021, we have seen a continued resurgence of demand due to the ongoing recovery of our business and the economy as a whole from the COVID-19 pandemic, which we expect to continue through year end and into 2022. However, numerous uncertainties remain regarding the potential future impact of the COVID-19 pandemic for the remainder of 2021 and beyond (including how the impact of the pandemic on our business and results of operations may change from quarter to quarter), including uncertainties related to the severity of the disease and the emergence of new variants, the continued duration of the pandemic, additional actions that may be taken by governmental authorities and other unintended consequences.

Table of Contents 22

Looking forward, our management will continue to actively monitor the impact of the global pandemic on our business, results of operations, financial condition, liquidity, suppliers, industry, investments and workforce. We do not currently anticipate any material impairments, with respect to intangible assets, long-lived assets, or right of use assets, increases in allowances for credit losses from our customers, other expenses, or changes in accounting judgments to have a material impact on our condensed consolidated financial statements.

On March 27, 2020, the CARES Act was signed into law to address the economic impact of the COVID-19 pandemic. On December 27, 2020, the Consolidated Appropriations Act, 2021 was signed into law and includes further relief and stimulus provisions to address economic concerns related to the COVID-19 pandemic. On March 11, 2021, the American Rescue Plan Act of 2021 was signed into law and provides further economic relief and stimulus to deal with the economic impact of the COVID-19 pandemic. We also continue to monitor any effects that may result from these Acts and other similar legislation or actions on our Company.

Non-GAAP Financial Measures

We include in this Quarterly Report on Form 10-Q the non-GAAP financial measures of EBITDA ~~from continuing operations~~ and Adjusted EBITDA ~~from continuing operations~~ and provide reconciliations from our most directly comparable GAAP financial measures to those measures.

We believe these financial measures provide users of our financial statements with supplemental information that may be useful in evaluating our operating performance. We also believe that such non-GAAP measures, when read in conjunction with our operating results presented under GAAP, can be used to better assess our performance from period to period and relative to performance of other companies in our industry, without regard to financing methods, historical cost basis or capital structure. These measures are not measures of financial performance or liquidity under GAAP and should be considered in addition to, and not as a substitute for, analysis of our results under GAAP.

WeTable ~~define EBITDA from continuing operations as net income (loss) from continuing operations plus interest expense, income tax expense (benefit), and depreciation and amortization. In the third quarter~~ of ~~2021,~~Contents we redefined our non-GAAP measure Adjusted EBITDA to also exclude one-time costs for professional services associated with M&A and strategic initiatives. We define Adjusted EBITDA from continuing operations as EBITDA from continuing operations net of the impact of items we do not consider indicative of our ongoing operating performance, including share-based compensation, gains or losses on disposal of assets, gains or losses on extinguishment of debt and one-time costs for professional services associated with M&A and strategic initiatives. The historical presentation of Adjusted EBITDA in this Quarterly Report on Form 10-Q has been recast to conform to the revised definition.15

~~The~~capital ~~following~~structure. ~~table~~These ~~presents~~measures aare ~~reconciliation~~not measures of ~~net~~financial ~~income~~performance ~~(loss),~~or ~~our~~liquidity ~~most~~under ~~directly comparable~~ GAAP ~~financial~~and ~~performance~~should ~~measure~~be ~~for~~considered ~~each~~in ofaddition ~~the periods presented~~to, toand ~~EBITDA~~not ~~from~~as ~~continuing~~a ~~operations~~substitute ~~and~~for, ~~Adjusted~~analysis ~~EBITDA~~of ~~from~~our ~~continuing~~results ~~operations~~under GAAP.

~~Table~~We define EBITDA as net income (loss) plus interest expense, income tax expense (benefit), and depreciation and amortization. In the third quarter of ~~Contents~~2021, 23we redefined our non-GAAP measure Adjusted EBITDA to also exclude costs for professional services associated with M&A and strategic initiatives. We define Adjusted EBITDA as EBITDA net of the impact of items we do not consider indicative of our ongoing operating performance, including share-based compensation, gains or losses on disposal of assets, gains or losses on extinguishment of debt, costs for professional services associated with M&A and strategic initiatives and other non-recurring costs. The historical presentation of Adjusted EBITDA in this Quarterly Report on Form 10-Q has been recast to conform to the revised definition.

	Three Months EndedSeptember 30, 2021
	Specialty Petrochemicals		Specialty Waxes		Corporate		Consolidated
	(in thousands)
Net income (loss)	$	2,619	$	2,670	$	(3,406)	$	1,883
Income from discontinued operations, net of tax	—		—		—		—
Income (loss) from continuing operations	$	2,619	$	2,670	$	(3,406)	$	1,883
Interest expense	318		—		1		319
Income tax expense (benefit)	1,444		—		(1,655)		(211)
Depreciation and amortization	195		23		—		218
Depreciation and amortization in cost of sales	2,649		1,530		—		4,179
EBITDA from continuing operations	$	7,225	$	4,223	$	(5,060)	$	6,388
Stock-based compensation	—		—		572		572
Gain on disposal of assets	12		—		—		12
Gain on extinguishment of debt(1)	—		(2,188)		—		(2,188)
One-time costs for professional services associated with M&A and strategic initiatives	—		—		2,751		2,751
Adjusted EBITDA from continuing operations	$	7,237	$	2,035	$	(1,737)	$	7,535
(1) Extinguishment of debt is directly related to the forgiveness of the TC PPP Loan as discussed in Note 11.

The following table presents a reconciliation of net income (loss), our most directly comparable GAAP financial performance measure for each of the periods presented, to EBITDA and Adjusted EBITDA.

	Three Months EndedSeptember 30, 2020
	Three Months EndedMarch 31, 2022
	Specialty Petrochemicals		Specialty Waxes		Corporate		Consolidated
	(in thousands)
Net income (loss)	$	41,~~161~~765	$	~~(1,267)~~324	$	19(2,~~538~~465)	$	~~22,432~~(376)
Loss from discontinued operations, net of tax	—		—		21,324		21,324
Interest expense	283		—		—		283
Income (loss) from continuing operations	$	4,161	$	(1,267)	$	(1,786)	$	1,108
Income tax expense (benefit)	597		—		(303)		294
Interest (income) expense	507		—		1		508
Depreciation and amortization	206		22		—		228
Income tax expense (benefit)	1,150		(26)		(271)		853
Depreciation and amortization in cost of sales	2,523		1,556		—		4,079
Depreciation and amortization	183		24		3		210
EBITDA	$	5,374	$	1,902	$	(2,768)	$	4,508
Depreciation and amortization in cost of sales	2,484		1,403		—		3,887
Stock-based compensation	—		—		524		524
EBITDA from continuing operations	$	8,485	$	134	$	(2,053)	$	6,566
Costs for professional services associated with M&A and strategic initiatives	—		—		210		210
Stock-based compensation	—		—		489		489
Other non-recurring costs*	515		—		—		515
One-time costs for professional services associated with M&A and strategic initiatives	—		—		35		35
Adjusted EBITDA	$	5,889	$	1,902	$	(2,034)	$	5,757
Adjusted EBITDA from continuing operations	$	8,485	$	134	$	(1,529)	$	7,090
* Represents non-recurring charitable contribution as discussed in Note 6.

Table of Contents 24


	Three Months Ended March 31, 2021
	Specialty Petrochemicals		Specialty Waxes		Corporate		Consolidated
	(in thousands)
Net income (loss)	$	205	$	(1,954)	$	(2,655)	$	(4,404)


Interest (income) expense	302		—		—		302
Income tax expense (benefit)	(486)		—		(515)		(1,001)
Depreciation and amortization	200		23		3		226
Depreciation and amortization in cost of sales	2,602		1,452		—		4,054
EBITDA	$	2,823	$	(479)	$	(3,167)	$	(823)
Stock-based compensation	—		—		571		571
Gain on disposal of assets	(254)		—		—		(254)

Costs for professional services associated with M&A and strategic initiatives	—		—		370		370
Adjusted EBITDA	$	2,569	$	(479)	$	(2,226)	$	(136)

	Nine Months EndedSeptember 30, 2021
	Specialty Petrochemicals		Specialty Waxes		Corporate		Consolidated
	(in thousands)
Net income (loss)	$	8,110	$	533	$	(8,909)	$	(266)
Income from discontinued operations, net of tax	—		—		—		—
Income (loss) from continuing operations	$	8,110	$	533	$	(8,909)	$	(266)
Interest expense	917		—		1		918
Income tax expense (benefit)	2,364		—		(2,873)		(509)
Depreciation and amortization	595		69		6		670
Depreciation and amortization in cost of sales	7,838		4,478		—		12,316
EBITDA from continuing operations	$	19,824	$	5,080	$	(11,775)	$	13,129
Stock-based compensation	—		—		1,695		1,695
Gain on disposal of assets	(280)		—		—		(280)
Gain on extinguishment of debt(1)	—		(2,188)		—		(2,188)
One-time costs for professional services associated with M&A and strategic initiatives	—		—		3,998		3,998
Adjusted EBITDA from continuing operations	$	19,544	$	2,892	$	(6,082)	$	16,354
(1) Extinguishment of debt is directly related to the forgiveness of the TC PPP Loan as discussed in Note 11.

	Nine Months EndedSeptember 30, 2020
	Specialty Petrochemicals		Specialty Waxes		Corporate		Consolidated
	(in thousands)
Net income (loss)	$	10,150	$	(385)	$	21,526	$	31,291
Income from discontinued operations, net of tax	—		—		26,179		26,179
Income (loss) from continuing operations	$	10,150	$	(385)	$	(4,653)	$	5,112
Interest expense	2,158		—		1		2,159
Income tax benefit	(249)		(1,595)		(2,098)		(3,942)
Depreciation and amortization	554		71		13		638
Depreciation and amortization in cost of sales	7,351		4,022		—		11,373
EBITDA from continuing operations	$	19,964	$	2,113	$	(6,737)	$	15,340
Stock-based compensation	—		—		1,422		1,422
(Gain) loss on disposal of assets	(8)		17		—		9
One-time costs for professional services associated with M&A and strategic initiatives	—		—		35		35
Adjusted EBITDA from continuing operations	$	19,956	$	2,130	$	(5,280)	$	16,806

Liquidity and Capital Resources

Working Capital

Our approximate working capital days are summarized as follows:

Table of Contents 2516

	September 30, 2021	December 31, 2020	September 30, 2020
	March 31, 2022	December 31, 2021	March 31, 2021
Days sales outstanding in accounts receivable	3936.43	40.05	4342.78
Days sales outstanding in inventory	1922.30	2026.51	2119.4
Days sales outstanding in accounts payable	1513.64	2214.9	2427.73
Days of working capital	4344.09	3751.76	4034.48

Our days sales outstanding in accounts receivable at ~~September~~March 3031, ~~2021~~2022 was 3936.43 days compared to 40.5 days at December 31, ~~2020~~2021. This decrease was primarily driven by relatively flat receivables as compared to the significant increase in sales revenue. Our days sales outstanding in inventory decreased by approximately 14.21 days from December 31, ~~2020. Our~~2021 ~~days~~as ~~sales~~we ~~outstanding~~sold inoff ~~accounts~~existing ~~payable~~inventory ~~decreased~~during ~~due~~a toscheduled ~~the~~plant ~~payment~~turnaround ~~of accrued accounts payable~~ at ~~December~~our ~~31,~~Specialty ~~2020,~~Petrochemicals ~~primarily~~facility ~~related~~late toin ~~maintenance~~the ~~spending~~first ~~and~~quarter ~~certain~~of ~~feedstock payables~~2022. Our Indays ~~addition,~~sales asoutstanding ~~our~~in ~~sales~~accounts ~~have~~payable ~~increased~~decreased ~~since~~due to the ~~end~~rising ofsales ~~last year~~revenue, ~~our~~while ~~days~~actual ~~sales~~accounts ~~outstanding~~payable inremained ~~inventory~~relatively ~~and~~flat ~~accounts~~as ~~payable~~compared ~~have~~to ~~decreased~~December 31, 2021. Since days of working capital is calculated using the above three metrics, it ~~increased~~decreased for the aforementioned reasons.

Our cash balance at ~~September~~March 3031, ~~2021~~2022 was $4431.49 million as compared to $5530.75 million at December 31, ~~2020~~2021.

The change in cash is summarized as follows:

~~Nine~~Three Months ~~EndedSeptember~~EndedMarch 3031,

2021

2020

2022

2021

Net cash provided by (used in)

(thousands of dollars)

Operating activities

97,~~316~~717

173,~~575~~831

Investing activities

(124,~~014~~851)

58(4,~~371~~500)

Financing activities

(81,~~563~~464)

(301,~~229~~969)

Increase (decrease) in cash

~~(11~~1,~~261)~~402

45(2,~~717~~638)

Cash

4431,~~403~~937

5153,~~862~~026

Operating Activities

Cash provided by operating activities totaled $97.37 million for the first ~~nine~~three months of ~~2021~~2022, $8.3.9 million ~~lower~~higher than the corresponding period in ~~2020~~2021. For the first ~~nine~~three months of ~~2021~~2022, net income ~~decreased~~increased approximately $314.60 million as compared to the corresponding period in ~~2020~~2021, driven primarily by ~~the~~higher ~~non-recurrence~~selling ofprices ~~the~~and ~~benefit~~expanding ~~of monetizing deferred taxes in 2020 under the CARES Act~~margins. Major non-cash items affecting income in the first ~~nine~~three months of ~~2021~~2022 included the impact of depreciation and amortization of $134.03 million, ~~forgiveness~~stock-based ofcompensation ~~one~~ of ~~the PPP Loans of approximately~~ $20.25 million, and ~~stock~~other non-~~based~~cash ~~compensation~~items of $10.75 million. Major non-cash items affecting income in the first ~~nine~~three months of ~~2020~~2021 included ~~the~~changes ~~impact~~in ofdepreciation ~~deferred~~and ~~taxes~~amortization of $144.23 million, ~~depreciation~~deferred ~~and~~taxes ~~amortization~~ of $~~12.~~(0.9) million, and stock-based compensation of $10.46 million.

Additional factors leading to the ~~decrease~~increase in cash provided by operating activities included:

•Trade receivables increased approximately $60.78 million, primarily due to increases in sales ~~volumes~~prices. We do not expect any collection issues at this time.

•Inventories ~~increased~~decreased approximately $20.78 million driven primarily by the ~~increase~~utilization of inventory to maintain customer shipments during a scheduled plant turnaround at our Specialty Petrochemicals facility late in ~~feedstock~~the ~~prices~~first quarter of 2022.

•Prepaid and other assets decreased $20.69 million. ~~primarily~~In ~~related~~2022, the Company elected to finance its insurance premiums, where in 2021 the ~~payment~~annual ofinsurance ~~our~~premium ~~foreign~~was ~~tax~~paid ~~liability~~in ~~and~~full ~~regular~~at ~~amortization~~the beginning of ~~our~~the ~~prepaid~~policy ~~insurance~~term.

•Accounts payable and accrued liabilities increased $21.45 million primarily due to ~~one-time~~accrued ~~costs for professional services associated with M&A and strategic initiatives~~payroll.

•The above items were offset by a decrease in taxes receivable of $1.8 million as we collected the remaining NOL carryback claims under the CARES Act.

Table of Contents 26

Investing Activities

Cash used in investing activities during the first ~~nine~~three months of ~~2021~~2022 was approximately $124.09 million, representing a ~~decrease~~increase of approximately $700.4 million from the corresponding period of ~~2020~~2021. The ~~outflow of the~~ funds used in investing activities during the first ~~nine~~three months of ~~2021~~2022 were for additions to property, plant and equipment ~~and the rebuild and restoration of property, plant and equipment associated with the Texas freeze event in February 2021 of approximately $12~~.3 ~~million, partially offset by approximately $0.3 million in proceeds from the sale of assets.~~ The ~~primary source of the~~ funds ~~provided~~used byin investing activities during the first ~~nine~~three months of ~~2020~~2021 ~~was~~were ~~$68.5~~for ~~million~~additions ofand ~~proceeds,~~rebuild ~~net~~and restoration of ~~the deposit previously paid~~property, ~~received~~plant inand ~~connection~~equipment ~~with the sale~~ of ~~our~~approximately ~~ownership~~$4.8 ~~interest~~million ~~in AMAK discussed in Note 5,~~ offset by ~~additions~~proceeds offrom ~~plant,~~the ~~pipeline~~sale ~~and equipment~~ of ~~approximately $10~~assets.~~3 million.~~


Table of Contents
			17

Financing Activities

Cash used in financing activities during the first ~~nine~~three months of ~~2021~~2022 was approximately $81.65 million versus cash used in financing activities of $~~30.~~2.0 million during the corresponding period of ~~2020~~2021. During the first ~~nine~~three months of ~~2021~~2022, we made mandatory payments totaling $31.31 million on our Term Loan Facility ~~and repurchased approximately $5~~.0 ~~million of shares of our common stock under our Share Repurchase Program.~~ During the first ~~nine~~three months of ~~2020~~2021, we ~~drew~~made ~~$20.0 million under the Revolving Facility as~~ a ~~precaution~~mandatory inpayment ~~light~~ of ~~the uncertainty caused by the COVID-19 pandemic. We also received PPP Loans of~~ $61.1 million ~~to maintain the continuity of our workforce, including maintaining compensation and benefits. Utilizing a portion of the net proceeds from the sale of our investment in AMAK, together with cash~~ on ~~hand, we repaid~~ our ~~outstanding balance on our Revolving Facility of $23 million at the end of the second quarter 2020 and further reduced our debt with a $30 million prepayment toward our~~ Term Loan Facility inand ~~the~~repurchased ~~third~~shares ~~quarter~~ of ~~2020.~~our Wecommon ~~also~~stock ~~made~~under ~~mandatory payments totaling $3.3 million on~~ our ~~Term~~Share ~~Loan~~Repurchase ~~Facility during the first nine months of 2020~~Program.

~~Anticipated~~Capital ~~Cash~~Resources ~~Needs~~and Requirements

AsCapital ofexpenditures ~~September~~increased ~~30, 2021, we have approximately~~ $440.41 million, inor ~~cash~~1%, ~~combined~~from ~~with~~2021 anto ~~available~~2022. ~~balance~~During onthe ~~our~~first ~~Revolving~~three ~~Facility~~months of ~~the~~2022 ~~full $75 million. As a result,~~ we ~~believe~~expended ~~the~~approximately ~~Company~~$1.5 ismillion ~~able to support its operating requirements and capital expenditures through internally generated funds supplemented with cash~~ on ~~our~~upgrades ~~balance~~to ~~sheet and availability under our ARC Agreement in both~~ the ~~short-term~~pipeline ~~(i.e.,~~for ~~the~~GSPL ~~next 12 months)~~ and ~~the~~approximately ~~long-term (i~~$0.e.7 ~~beyond~~million ~~the~~for ~~next~~a 12scheduled ~~months)~~plant turnaround.

At March 31, 2022, we had $31.9 million in cash and cash equivalents and borrowing availability of approximately $75 million on our Revolving Facility. We believe the Company is able to support its operating requirements and capital expenditures through internally generated funds supplemented with cash on our balance sheet and availability under our ARC Agreement in both the short-term (i.e., the next 12 months) and the long-term (i.e. beyond the next 12 months). See Note 11 for additional discussion regarding credit availability.

Our material cash requirements include the following contractual and other obligations.

Debt. Long-term debt obligations approximate $40.9 million as discussed in Note 10.

Leases. The majority of our approximately $7.3 million of operating lease obligations are for railcars as discussed in Note 8.

Other Purchase Obligations. Purchase obligations of approximately $28.3 million are primarily related to commitments for our undelivered feedstock and capital construction projects as discussed in Note 12.

Results of Operations

Comparison of Three Months Ended ~~September~~March 3031, ~~2021~~2022 and ~~2020~~2021

Table of Contents 2718

Specialty Petrochemicals Segment	Three Months Ended ~~September~~March 3031,
	2021			2020			Change		% Change
	2022			2021			Change		% Change
	(thousands of dollars)
Product Sales	$	6169,~~938~~090		$	3744,~~580~~658		$	24,~~358~~432	6454.87	%
Processing	1,~~419~~488			1,~~644~~254			~~(225)~~234		~~(13~~18.7)	%
Gross Revenue	$	6370,~~357~~578		$	3945,~~224~~912		$	24,~~133~~666	6153.57	%
Volume of Sales (gallons)
Specialty Petrochemicals Products	20,~~862~~223			17,~~868~~201			23,~~994~~022		1617.86	%
Prime Product Sales	1716,~~180~~556			14,~~734~~675			21,~~446~~881		1612.68	%
By-product Sales	3,~~682~~667			32,~~134~~526			~~548~~1,141		1745.52	%
Cost of Sales	$	5664,~~069~~363		$	3042,~~732~~869		2521,~~337~~494		8250.41	%
Gross Margin	118.58		%	216.76		%			~~(10~~2.2)	%
Total Operating Expense*	1921,~~543~~348			1720,~~122~~357			~~2,421~~991		144.19	%
Natural Gas Expense*	12,~~735~~009			~~867~~2,976			~~868~~(967)		~~100~~(32.15)	%
Operating Labor Costs*	23,~~901~~199			43,~~046~~348			(~~1,145~~149)		(284.35)	%
Transportation Costs*	56,~~936~~280			54,~~645~~606			~~291~~1,674		536.23	%
General & Administrative Expense	23,~~681~~355			23,~~438~~074			~~243~~281		109.01	%
Depreciation and Amortization**	2,~~844~~729			2,~~667~~802			~~177~~(73)		6(2.6)	%
Capital Expenditures	3,416			2,084			1,332		63.9	%
Adjusted EBITDA	5,889			2,569			3,320		129.2	%
Capital Expenditures	4,129			3,567			562		15.8	%

* Included in cost of sales

**Includes $2,~~650~~523 and $2,~~484~~602 for ~~2021~~the first quarter of 2022 and ~~2020~~2021, respectively, which is included in operating expense

Gross Revenue

Gross Revenue for our Specialty Petrochemicals segment increased for the ~~third~~first quarter ~~2021~~2022 compared to the ~~third~~first quarter ~~2020~~2021 by 6153.57%, primarily due to higher ~~sales~~selling ~~volumes~~prices and higher ~~selling~~sales ~~prices~~volumes for prime products and by-products which were ~~previously~~adversely impacted byduring the ~~COVID-19~~first ~~pandemic~~quarter inof 2021 by the ~~third~~Texas ~~quarter~~freeze ofevent ~~2020~~and the ongoing COVID-19 pandemic.

Product Sales

Specialty Petrochemicals segment product sales increased approximately 6454.87% for the ~~third~~first quarter ~~2021~~2022 compared to the ~~third~~first quarter ~~2020~~2021. Prime products sales volume increased approximately 21.49 million gallons, or 1612.68%, from the ~~third~~first quarter ~~2020~~2021, ~~driven~~which ~~primarily~~increase bywas ~~the~~driven ~~continued~~by continued increase in economic activity, including strong demand from many of our end-use markets, during the first quarter of 2022 together with the adverse impact of the Texas freeze event in the first quarter of 2021. By-product sales volumes in ~~third~~first quarter ~~2021~~2022 increased 1745.52% compared to the ~~third~~first quarter ~~2020~~2021. By-products are produced as a result of prime product production and their margins are significantly lower than margins for our prime products. Foreign sales volume ~~decreased~~increased to 1719.62% of total Specialty Petrochemicals volume in the ~~third~~first quarter for ~~2021~~2022 compared to 2417.68% in the ~~third~~first quarter ~~2020~~2021. Foreign sales volume includes sales to Canadian oil sands customers.

Processing

Processing revenues were $1.45 million in the ~~third~~first quarter ~~2021~~2022 compared to $1.63 million for the ~~third~~first quarter ~~2020~~2021.

Cost of Sales (includes but is not limited to raw materials and total operating expense)

We use natural gasoline as feedstock, which is the heavier liquid remaining after ethane, propane and butanes are removed from liquids produced by natural gas wells. The material is a commodity product in the oil/petrochemical markets and generally is readily available. The price of natural gasoline is highly correlated with the price of crude oil. Our Advanced Reformer unit upgrades the by-product stream produced as a result of prime product production. This upgrade allows us to sell our by-products at higher prices than would be possible without the Advanced Reformer unit.

~~Cost~~Table of ~~sales~~Contents increased 82.4% for the third quarter 2021 compared to the third quarter 2020. The increase in cost of sales compared to the same period last year was driven by significantly higher sales volumes, increased feedstock prices and higher utility costs. Benchmark Mont Belvieu natural gasoline feedstock price increased by 103% from $0.80 per gallon in third quarter 2020 to $1.62 per gallon in the third quarter 2021. Sharp increases in feedstock costs were only partially offset by 19

~~Table~~Cost of ~~Contents~~sales 28increased 50.1% for the first quarter 2022 compared to the first quarter 2021. The increase in cost of sales compared to the same period last year was driven by significantly higher sales volumes and increased feedstock prices. Benchmark Mont Belvieu natural gasoline feedstock price increased 66% from $1.33 per gallon in first quarter 2021 to $2.21 per gallon in the first quarter 2022. By-product margins were higher compared to the first quarter of 2021. This was due to higher component prices.

~~product~~The ~~price~~gross ~~increases~~margin ~~which~~percentage ~~led~~for tothe ~~gross~~Specialty ~~margin~~Petrochemicals ~~decline~~segment inincreased from 6.6% for the ~~third~~first quarter of 2021 ~~compared~~ to ~~third quarter of 2020~~8.8% ~~By-product~~in ~~margins were higher compared to~~ the ~~third~~first quarter of ~~2020~~2022. ~~This was due to higher component prices.~~

The gross margin percentage for the Specialty Petrochemicals segment decreased from 21.7% for the third quarter of 2020 to 11.5% in the third quarter of 2021.

Total Operating Expense (includes but is not limited to natural gas, operating labor, depreciation and transportation)

Total Operating Expense increased $21.40 million, or 144.19%, for the ~~third~~first quarter ~~2021~~2022 compared to the same period in ~~2020~~2021, primarily due to ~~higher~~costs ~~natural~~associated ~~gas~~with ~~and~~a scheduled plant turnaround of approximately $2.4 million combined with higher transportation costs and offset by ~~outsourcing~~lower ofnatural ~~certain~~gas ~~operating labor~~costs.

Capital Expenditures

Capital expenditures in the ~~third~~first quarter ~~2021~~2022 were approximately $3.4.1 million compared to $23.16 million in the ~~third~~first quarter of ~~2020~~2021. ~~Third~~First quarter ~~2021~~2022 capital expenditures were primarily for maintenance and upkeep of our GSPL pipeline, which is used to transport our feedstock, of approximately $1.5 million and a scheduled plant turnaround of approximately $0.7 million.

Specialty Waxes Segment	Three Months Ended ~~September~~March 3031,
	2021			2020			Change		% Change
	2022			2021			Change		% Change
	(thousands of dollars)
Product Sales	$	89,~~484~~971		$	56,~~990~~907		$	23,~~494~~064	4144.64	%
Processing	2,~~796~~665			21,~~533~~766			~~263~~899		1050.49	%
Gross Revenue	$	1112,~~280~~636		$	8,~~523~~673		$	23,~~757~~963	3245.37	%
Volume of specialty wax sales (thousand pounds)	910,~~786~~328			8,~~821~~826			~~965~~1,502		1017.90	%
Cost of Sales	$	910,~~595~~958		$	89,~~558~~321		$	1,~~037~~637	1217.16	%
Gross Margin (Loss)	1413.93		%	(07.45)		%			1520.38	%
General & Administrative Expense	1,~~175~~324			1,~~278~~235			~~(103)~~89		(87.1)2	%
Depreciation and Amortization*	1,~~553~~578			1,~~427~~476			~~126~~102		86.89	%
Capital Expenditures	$	215		$	641		$	(426)	(66.5)	%
Adjusted EBITDA	$	324		$	(479)		803		(167.6)	%
Capital Expenditures	$	722		$	1,214		$	(492)	(40.5)	%

*Includes $1,~~530~~556 and $1,~~403~~452 for ~~2021~~2022 and ~~2020~~2021, respectively, which is included in cost of sales

Product Sales

Product sales revenue for the Specialty Waxes segment increased by 4144.64% for the ~~third~~first quarter of ~~2021~~2022 compared to the ~~third~~first quarter of ~~2020~~2021 due to higher selling prices and volumes. Average selling prices for our specialty waxes increased approximately 2822% as compared to the same period last year. Specialty wax sales volume increased approximately 1.05 million pounds in the ~~third~~first quarter of ~~2021~~2022 compared to the ~~third~~first quarter of ~~2020~~2021. Our wax feed is based on certain by-products produced as a result of polyethylene production at major polyethylene producers' facilities on the US Gulf Coast.

Processing

Processing revenues were $2.87 million for the ~~third~~first quarter ~~2021~~2022, a $0.39 million increase compared to the ~~third~~first quarter ~~2020~~2021. The first quarter of 2021 was adversely impacted by the Texas freeze event and the ongoing COVID-19 pandemic.

Cost of sales

Cost of sales increased by 1217.16%, or approximately $1.06 million, in the ~~third~~first quarter ~~2021~~2022 compared to the ~~third~~first quarter ~~2020~~2021. This increase was driven by higher polyethylene wax feed cost and higher purchase prices ~~as well as increased utility charges~~.

Depreciation

Depreciation for the ~~third~~first quarter ~~2021~~2022 was $1.6 million, a $0.1 million increase compared to the ~~third~~first quarter of ~~2020~~2021.


Table of Contents
			20

Capital Expenditures

Capital Expenditures were approximately $0.27 million in the ~~third~~first quarter ~~2021~~2022 compared to $01.62 million in the ~~third~~first quarter of ~~2020~~2021.

Table of Contents 29


Corporate Segment	Three Months Ended March 31,
	2022		2021		Change		% Change
	(thousands of dollars)
General & Administrative Expense	$	2,854	$	3,023	$	(169)	(5.6)	%

Corporate Segment	Three Months Ended September 30,
	2021		2020		Change		% Change
	(thousands of dollars)
General & Administrative Expense	$	5,555	$	2,049	$	3,506	171.1	%

Corporate expenses decreased $0.2 million in the first quarter of 2022 compared to the first quarter of 2021 primarily due to reduced accounting and consulting fees.

Corporate expenses increased $3.5 million in the third quarter of 2021 compared to the third quarter of 2020 primarily due to one-time costs for professional services associated with M&A and strategic initiatives as well as higher insurance costs.

Investment in AMAK - Discontinued Operations	Three Months Ended September 30,
	2021		2020		Change		% Change
	(thousands of dollars)
Equity in earnings of AMAK	$	—	$	682	$	(682)	100.0	%

Equity in earnings of AMAK decreased due to the completion of the sale of our ownership interest in AMAK during the third quarter of 2020. See Note 5 for additional discussion.

Results of Operations

Comparison of Nine Months Ended September 30, 2021 and 2020

Specialty Petrochemicals Segment	Nine Months Ended September 30,
	2021			2020			Change		% Change
	(thousands of dollars)
Product Sales	$	164,359		$	119,202		$	45,157	37.9	%
Processing	4,200			4,047			153		3.8	%
Gross Revenue	$	168,559		$	123,249		$	45,310	36.8	%
Volume of Sales (gallons)
Specialty Petrochemicals Products	58,038			52,952			5,086		9.6	%
Prime Product Sales	48,716			44,042			4,674		10.6	%
By-product Sales	9,322			8,910			412		4.6	%
Cost of Sales	$	148,144		$	102,654		45,490		44.3	%
Gross Margin	12.1		%	16.7		%			(4.6)	%
Total Operating Expense*	57,438			50,022			7,416		14.8	%
Natural Gas Expense*	4,604			2,479			2,125		85.7	%
Operating Labor Costs*	9,683			11,984			(2,301)		(19.2)	%
Transportation Costs*	16,640			15,422			1,218		7.9	%
General & Administrative Expense	8,684			7,944			740		9.3	%
Depreciation and Amortization**	8,433			7,905			528		6.7	%
Capital Expenditures	10,675			9,067			1,608		17.7	%

* Included in cost of sales

**Includes $7,838 and $7,351 for 2021 and 2020, respectively, which is included in operating expense

Gross Revenue

Gross Revenue for our Specialty Petrochemicals segment increased during the first nine months of 2021 from the first nine months of 2020 by 36.8%, primarily due to higher sales volumes for prime products and byproducts. An increase in average selling prices resulting from an increase in feedstock costs also contributed to the higher revenues.

Table of Contents 30

Product Sales

Specialty Petrochemicals segment product sales increase approximately 37.9% during the first nine months of 2021 from the first nine months of 2020, primarily as a result of higher sales volumes and higher selling prices driven by formula based pricing. Prime products sales volume increased approximately 4.7 million gallons, or 10.6%, from the first nine months of 2020 due to higher demand. Sales in the first nine months of 2020 were generally weaker as a result of the impact of the COVID-19 pandemic. By-product sales volumes in the first nine months of 2021 increased 4.6% compared to the first nine months of 2020. By-products are produced as a result of prime product production and their margins are significantly lower than margins for our prime products. Foreign sales volume decreased to 19.1% of total Specialty Petrochemicals volume in the first nine months of 2021 from 24.4% in the first nine months of 2020. Foreign sales volume includes sales to Canadian oil sands customers.

Processing

Processing revenues were approximately $4.2 million and $4.0 million for the first nine months of 2021 and 2020, respectively.

Cost of Sales (includes but is not limited to raw materials and total operating expense)

Cost of Sales increased 44.3% during the first nine months of 2021 from the first nine months of 2020. The increase in cost of sales compared to the same period last year was driven by higher sales volumes, higher feedstock costs and higher operating expenses – primarily natural gas and transportation costs. Benchmark Mount Belvieu natural gasoline feedstock price increased 104% from $0.72 per gallon in the first nine months of 2020 to $1.47 per gallon in the first nine months of 2021. By-product margins were higher compared to the first nine months of 2020. This was due to higher component prices.

The gross margin percentage for the Specialty Petrochemicals segment decreased from 16.7% in the first nine months of 2020 to 12.1% in the first nine months of 2021 driven by increasing feedstock costs as well as higher operating expenses which were partially offset by product price increases.

Total Operating Expense (includes but is not limited to natural gas, operating labor, depreciation and transportation)

Total Operating Expense increased $7.4 million, or 14.8%, during the first nine months of 2021 from the same period in 2020. Operating expenses were impacted by higher natural gas and transportation costs.

Capital Expenditures

Capital expenditures in the first nine months of 2021 were approximately $10.7 million compared to $9.1 million in the first nine months of 2020. The first nine months of 2021 included approximately $3.8 million for restoration and upkeep of our GSPL pipeline which is used to transport our feedstock. Additionally, the first nine months of 2021 included tower replacement and feed tank restoration costs of approximately $1.5 million as well as restoration costs associated with the damage to plant equipment due to the Texas freeze event in February 2021.

Specialty Waxes Segment	Nine Months Ended September 30,
	2021			2020			Change		% Change
	(thousands of dollars)
Product Sales	$	22,288		$	18,258		$	4,030	22.1	%
Processing	7,224			8,981			(1,757)		(19.6)	%
Gross Revenue	$	29,512		$	27,239		$	2,273	8.3	%
Volume of specialty wax sales (thousand pounds)	27,411			27,361			50		0.2	%
Cost of Sales	$	27,588		$	25,132		$	2,456	9.8	%
Gross Margin (Loss)	6.5		%	7.7		%			(1.2)	%
General & Administrative Expense	3,522			4,120			(598)		(14.5)	%
Depreciation and Amortization*	4,547			4,093			454		11.1	%
Capital Expenditures	$	1,620		$	1,242		$	378	30.4	%

*Includes $4,478 and $4,022 for 2021 and 2020, respectively, which is included in cost of sales

Table of Contents 31

Product Sales

Specialty Wax segment product sales revenue increased approximately $4.0 million, or 22.1%, during the first nine months of 2021 from the first nine months of 2020. Product sales revenue increased as we were successful in increasing selling prices for our specialty waxes in excess of increases in wax feed costs. Specialty wax sales volume increased slightly, while average selling prices increased due to higher wax pricing and a change in mix of sales to domestic versus export customers. Our wax feed is based on certain by-products produced as a result of polyethylene production at major polyethylene producers' facilities on the US Gulf Coast.

Processing

Processing revenues were $7.2 million in the first nine months of 2021, a decrease of 19.6% from the first nine months of 2020, or about $1.8 million. The decrease was primarily due to the continuing pandemic along with the impact of the Texas freeze event in February 2021.

Cost of Sales

Cost of Sales increased 9.8%, or nearly $2.5 million, in the first nine months of 2021 compared to the first nine months of 2020. This increase was driven by higher polyethylene wax feed cost and higher purchase prices as well as increased utility charges related to the Texas freeze event.

General and Administrative

General and administrative expenses decreased approximately $0.6 million in the first nine months of 2021 compared to the first nine months of 2020.

Depreciation

Depreciation for the first nine months of 2021 was $4.5 million, a $0.5 million increase from the first nine months of 2020.

Capital Expenditures

Capital Expenditures were approximately $1.6 million in the first nine months of 2021 compared with $1.2 million in the first nine months of 2020. Capital expenditures primarily relate to restoration costs associated with the damage to pipes and other plant equipment due to the Texas freeze event in February 2021.

Corporate Segment	Nine Months Ended September 30,
	2021		2020		Change		% Change
	(thousands of dollars)
General & Administrative Expense	$	11,722	$	6,664	$	5,058	75.9	%

General corporate expenses increased by $5.1 million during the first nine months of 2021 from the first nine months of 2020. The increase is primarily attributable to one-time costs for professional services associated with M&A and strategic initiatives as well as higher insurance costs.

Investment in AMAK - Discontinued Operations	Nine Months Ended September 30,
	2021		2020		Change		% Change
	(thousands of dollars)
Equity in earnings of AMAK	$	—	$	455	$	(455)	(100.0)	%

Equity in earnings of AMAK decreased due to the completion of the sale of our ownership interest in AMAK during the third quarter of 2020. See Note 5 for additional discussion.

Contractual Obligations

Our contractual obligations are summarized in Part II, Item 7. “Management's Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no other material changes to the contractual obligation amounts disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020.

Critical Accounting Policies and Estimates

~~Table~~For a description of ~~Contents~~our 32critical accounting policies and estimates, refer to the information under the caption “Critical Accounting Estimate” in “Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations” in the Annual Report on Form 10-K, as amended. There have been no material changes to our critical accounting policies and estimates since the Annual Report on Form 10-K, as amended.

Critical accounting policies are more fully described in Note 2, “RECENT ACCOUNTING PRONOUNCEMENTS” to the consolidated financial statements set forth in our Annual Report on Form 10-K for the year ended December 31, 2020. The preparation of the condensed consolidated financial statements in accordance with generally accepted accounting principles requires management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the period reported. By their nature, these estimates, assumptions and judgments are subject to an inherent degree of uncertainty. We base our estimates, assumptions and judgments on historical experience, market trends and other factors that are believed to be reasonable under the circumstances. Estimates, assumptions and judgments are reviewed on an ongoing basis and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Actual results may differ from these estimates under different assumptions or conditions. Our critical accounting policies and estimates have been discussed with the Audit Committee of the Board of Directors and discussed in ~~our~~the Annual Report on Form 10-K ~~for the year ended December 31~~, ~~2020~~as amended. For the ~~nine~~three months ended ~~September~~March 3031, ~~2021~~2022, there were no significant changes to these policies.

Recent and New Accounting Standards

See Note 2 for a summary of recent accounting guidance.

Off Balance Sheet Arrangements

As of September 30, 2021, we do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial statements, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

For quantitative and qualitative disclosure about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk” in ~~our~~the Annual Report on Form 10–-K ~~for the year ended December 31~~, ~~2020~~as amended. There have been no material changes in the Company's exposure to market risk from the disclosure included in such report.

ITEM 4. CONTROLS AND PROCEDURES.

(a)Evaluation of disclosure controls and procedures. Our Chief Executive Officer and Chief Financial Officer, with the participation of management, have evaluated the effectiveness of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15(d)-15(e) under the Securities Exchange Act of 1934) and determined that our disclosure controls and procedures were effective as of the end of the period covered by this report.

(b)Changes in internal control. There were no significant changes in our internal control over financial reporting that occurred during the three months ended ~~September~~March 3031, ~~2021~~2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents 3321

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The Company is periodically named in legal actions arising from normal business activities. The Company evaluates the merits of these actions and, if it determines that an unfavorable outcome is probable and can be reasonably estimated, the Company will establish the necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.

ITEM 1A. RISK FACTORS.

Readers of this Quarterly Report on Form 10–Q should carefully consider the risks described in the Company's other reports and filings filed with or furnished to the SEC, including the Company's prior and subsequent reports on Forms 10-K, 10-Q and 8-K, in connection with any evaluation of the Company's financial position, results of operations and cash flows.

The risks and uncertainties in the ~~Company's most recent~~ Annual Report on Form 10-K, as amended, are not the only risks that the Company faces. Additional risks and uncertainties not presently known or those that are currently deemed immaterial may also affect the Company's operations. Any of the risks, uncertainties, events or circumstances described therein could cause the Company's future financial condition, results of operations or cash flows to be adversely affected. There have been no material changes from the risk factors previously disclosed in the ~~Company's~~ Annual Report on Form 10-K, ~~for~~as ~~the~~amended, ~~year~~except ~~ended~~as ~~December~~described ~~31, 2020.~~below:

The ongoing military action between Russia and Ukraine could adversely affect our business, results of operations, financial condition and cash flows.

In February of 2022, Russian military forces invaded Ukraine. Although the length, impact, and outcome of the ongoing military conflict in Ukraine is highly unpredictable, this conflict could lead to significant market and other disruptions, including significant volatility in commodity prices, instability in financial markets, higher inflation, supply chain interruptions, political and social instability, changes in consumer or purchaser preferences as well as increase in cyberattacks and espionage. As a result, governments in the European Union, the United States, the United Kingdom, Switzerland, and other countries have enacted additional sanctions against Russia and Russian interests. Such sanctions, and other measures, as well as the existing and potential further responses from Russia or other countries to such sanctions, supply chain disruptions, tensions and military actions, could adversely affect the global economy and financial markets and could adversely affect our business, results of operations, financial condition and cash flows.

ITEM 6. EXHIBITS.

The following documents are filed or incorporated by reference as exhibits to this Report. ~~Exhibits marked with an asterisk (*) are filed herewith.~~

ExhibitNumber			Description
31.1*			Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
31.2*			Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
32.1*			Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.1**			Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*			Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**			Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*			XBRL Instance Document (XBRL tags are embedded within the Inline XBRL document)
101.SCH*			XBRL Taxonomy Schema Document
101.CAL*			XBRL Taxonomy Calculation Linkbase Document
101.LAB*			XBRL Taxonomy Label Linkbase Document
101.PRE*			XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF*			XBRL Taxonomy Extension Definition Linkbase Document
104*			Cover Page Interactive Data File (formatted as inline XBRL and included as Exhibit 101)

* Filed herewith.

** Furnished herewith.

SIGNATURES


Table of Contents
			22

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TRECORA RESOURCES
Dated: November 4, 2021	By:	/s/ Sami Ahmad
Dated: May 5, 2022	By:	/s/ Sami Ahmad
		Sami Ahmad
		Principal Financial Officer and Duly Authorized Officer

Table of Contents 3423

Filing Compare · TRECORA RESOURCES